var data={"specialtyName":"Authors and Editors in Hematology","contributorTypes":

[{"name":"Editors-in-Chief","contributors":[{"name":"Richard A Larson,
MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor —
Leukemia\n","Professor of Medicine\n","University of Chicago Pritzker School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [leukemia
(gilteritinib)]; Erytech [leukemia (eryaspase)]; Novartis [leukemia (nilotinib,
ascininib)]; Daiichi Sankyo [leukemia (quizartinib)]; Celgene [leukemia
(enasidenib)]. Consultant/Advisory Boards: Novartis [leukemia (imatinib,
nilotinib)]; Ariad Data Safety Monitoring Board [leukemia (ponatinib)];
CVS/Caremark [leukemia (drug prior authorization program)]; Celgene Data Safety
Monitoring Board [leukemia (azacitidine, durvalumab)]; Amgen [leukemia
(blinatumomab)]; Astellas [leukemia (gilteritinib)]; Jazz [leukemia (CPX-351)]."},
{"name":"Lawrence LK Leung, MD","credentials":["Editor-in-Chief —
Hematology\n","Section Editor — Disorders of Hemostasis and
Coagulation\n","Professor of Medicine\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Stanley L Schrier, MD","credentials":["Editor-
in-Chief — Hematology\n","Section Editor — Myeloproliferative Disorders; Red Blood
Cell Disorders\n","Professor of Medicine\n","Stanford University School of
Medicine"],"disclosure":""}]},{"name":"Deputy Editors","contributors":
[{"name":"Rebecca F Connor, MD","credentials":["Senior Deputy Editor —
UpToDate\n","Deputy Editor — Hematology"],"disclosure":""},{"name":"Alan G
Rosmarin, MD","credentials":["Deputy Editor — Hematology\n","Professor of
Medicine\n","University of Massachusetts Medical School"],"disclosure":""},
{"name":"Jennifer S Tirnauer, MD","credentials":["Deputy Editor —
Hematology"],"disclosure":""}]},{"name":"Section Editors","contributors":
[{"name":"Nelson J Chao, MD","credentials":["Section Editor — Bone Marrow
Transplantation\n","Professor of Medicine\n","Duke University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Jazz [GVHD
(defibrotide)]; NIH [hematopoiesis]."},{"name":"Arnold S Freedman,
MD","credentials":["Section Editor — Lymphoproliferative Disorders\n","Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Kahr Therapeutics [SAB]. Other Financial Interest: Novartis [DMB (Ofatumumab)];
Bayer [DMB (Bayer 17833)]."},{"name":"Steven Kleinman, MD","credentials":["Section
Editor — Transfusion Medicine\n","Clinical Professor of Pathology\n","University of
British Columbia, Vancouver"],"disclosure":"Consultant/Advisory Boards: Cerus Corp
[Pathogen reduction of blood components (Intercept Blood system)]. Equity
Ownership/Stock Options: Cerus Corp."},{"name":"Timothy M Kuzel, MD,
FACP","credentials":["Section Editor — Lymphoproliferative Disorders \n","Professor
of Medicine, Rush University Medical Center\n","Chief, Division of
Hematology/Oncology/Cell Therapy"],"disclosure":"Grant/Research/Clinical Trial
Support: Seattle Genetics [CTCL (brentuximab vedotin)]; Kyowa [CTCL (anti CCR4
antibody)]; Celgene [CTCL (romidepsin)]; Esai [CTCL (denileukin diftitox)].
Speaker's Bureau: Celgene [CTCL (romidepsin)]. Consultant/Advisory Boards: Amgen
[CTCL and melanoma]; Eisai [CTCL and renal cell CA]."},{"name":"Robert A Kyle,
MD","credentials":["Section Editor — Plasma Cell Disorders\n","Professor of
Medicine\n","Mayo Medical School"],"disclosure":"Consultant/Advisory Boards:
Celgene Disease Monitoring Committee [Dysproteinemias (lenalidomide,
pomalidomide)]; Bristol-Myers Squibb Independent Monitoring Committee
[Dysproteinemias (elotuzumab)]; Onyx Pharma (Amgen) Data Monitoring Committee
[Dysproteinemias (carfilzomib)]; Pharmacyclics Data Safety Monitoring Board
[Dysproteinemias (ibrutinib)]. Other Financial Interest: Pfizer [Lecture on therapy
of multiple myeloma, made comments concerning a new Pfizer product and received an
honorarium]."},{"name":"Richard A Larson, MD","credentials":["Editor-in-Chief —
Hematology\n","Section Editor — Leukemia\n","Professor of Medicine\n","University
of Chicago Pritzker School of Medicine"],"disclosure":"Grant/Research/Clinical
Trial Support: Astellas [leukemia (gilteritinib)]; Erytech [leukemia (eryaspase)];
Novartis [leukemia (nilotinib, ascininib)]; Daiichi Sankyo [leukemia
(quizartinib)]; Celgene [leukemia (enasidenib)]. Consultant/Advisory Boards:
Novartis [leukemia (imatinib, nilotinib)]; Ariad Data Safety Monitoring Board
[leukemia (ponatinib)]; CVS/Caremark [leukemia (drug prior authorization program)];
Celgene Data Safety Monitoring Board [leukemia (azacitidine, durvalumab)]; Amgen
[leukemia (blinatumomab)]; Astellas [leukemia (gilteritinib)]; Jazz [leukemia (CPX-
351)]."},{"name":"Lawrence LK Leung, MD","credentials":["Editor-in-Chief —
Hematology\n","Section Editor — Disorders of Hemostasis and
Coagulation\n","Professor of Medicine\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Andrew Lister, MD, FRCP, FRCPath,
FRCR","credentials":["Section Editor — Lymphoproliferative Disorders\n","Professor
of Medical Oncology\n","St. Bartholomew's Hospital,
London"],"disclosure":"Consultant/Advisory Boards: Celgene [malignant lymphoma],
Pfizer [Lymphoma (anti-CD20 biosimilars)], Gilead (data monitoring committee) [CLL,
indolent lymphoma (idelalisib [CAL 101])], Roche (data monitoring committee)
[Indolent lymphoma (obinutuzumab [GA101])], Millennium/Takeda (data monitoring
committee) [Hodgkin lymphoma (brentuximab vedotin)]; Merck (pembrolizumab). Equity
Ownership/Stock Options (Spouse also): GSK; Johnson & Johnson; AstraZeneca;
Novartis; Pfizer; Hikma Pharma."},{"name":"Bob Lowenberg, MD, PhD","credentials":
["Section Editor — Leukemia\n","Professor and Chairman, Department of
Hematology\n","Erasmus University Medical Center, The
Netherlands"],"disclosure":"Consultant/Advisory Boards: Clear Creek Bio [Acute
myeloid leukemia (Brequinar)]; Celgene [Acute myeloid leukemia (Enasidenib)]; AGIOS
[Acute myeloid leukemia (Ivosidenib)]; Astellas [Acute myeloid leukemia
(Gilteritinib)]; F. Hoffmann-La Roche; AbbVie [Acute myeloid leukemia
(Venetoclax)]."},{"name":"Pier Mannuccio Mannucci, MD","credentials":["Section
Editor — Disorders of Hemostasis and Coagulation\n","Professor of Internal
Medicine, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center\n","University of
Milan, Italy"],"disclosure":"Speaker's Bureau: Shire, Bayer, Grifols, Kedrion
Biopharma, Novo Nordisk, LFB [hemophilia, coagulation disorders].
Consultant/Advisory Boards: Bayer, Kedrion Biopharma [hemophilia, coagulation
disorders]."},{"name":"William C Mentzer, MD","credentials":["Section Editor — Red
Cell Disorders\n","Professor of Pediatrics\n","University of California, San
Francisco"],"disclosure":"Equity Ownership/Stock Options: Johnson & Johnson [Anemia
(Erythropoietin)]."},{"name":"Robert S Negrin, MD","credentials":["Section Editor —
Bone Marrow Transplantation\n","Professor of Medicine\n","Stanford University
School of Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen [Immuno-
oncology]; Jazz Pharmaceuticals [Veno-occlusive disease (Defibrotide)]; Cell Source
[Cellular therapy]; Magenta Pharmaceuticals [Transplantation]. Equity
Ownership/Stock Options: Concentrx [Cellular immunotherapy]; Magenta
Pharmaceuticals [Transplantation]; Cell Source [Cellular therapy]. Other Financial
Interest: American Society of Hematology [Editor in Chief of \"Blood
Advances\"]."},{"name":"Peter Newburger, MD","credentials":["Section Editor — White
Blood Cell Disorders\n","Ali and John Pierce Professor of Pediatric
Hematology/Oncology\n","University of Massachusetts Medical
School"],"disclosure":""},{"name":"Julie R Park, MD","credentials":["Section Editor
— Lymphoma; Pediatric Oncology\n","Professor of Pediatrics\n","University of
Washington"],"disclosure":""},{"name":"Stanley L Schrier, MD","credentials":
["Editor-in-Chief — Hematology\n","Section Editor — Myeloproliferative Disorders;
Red Blood Cell Disorders\n","Professor of Medicine\n","Stanford University School
of Medicine"],"disclosure":""},{"name":"Arthur J Silvergleid, MD","credentials":
["Section Editor — Transfusion Medicine\n","Affiliate Associate Professor,
Department of Pathology and Cell Biology\n","University of South Florida, College
of Medicine\n","Medical Director, OneBlood, Inc."],"disclosure":""}]},
{"name":"Editorial Assistants","contributors":[{"name":"Michael F Bottari,
BA","credentials":["Editorial Assistant — UpToDate"],"disclosure":""}]},
{"name":"Authors","contributors":[{"name":"Vikki M Abrahams, PhD","credentials":
["Associate Professor \n","Yale University School of Medicine"],"disclosure":""},
{"name":"Charles S Abrams, MD","credentials":["Professor of Medicine\n","University
of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Steven B Abramson,
MD","credentials":["Professor of Medicine and Pathology\n","New York University
School of Medicine"],"disclosure":""},{"name":"M Jacob Adams, MD,
MPH","credentials":["Associate Professor (retired)\n","University of Rochester
School of Medicine and Dentistry"],"disclosure":""},{"name":"Anjali S Advani,
MD","credentials":["Director, Inpatient Leukemia Unit\n","Associate Professor,
Cleveland Clinic Lerner College of Medicine\n","Staff, Department of
Hematology/Oncology\n","Taussig Cancer Institute, The Cleveland
Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen (ALL
[blinotumomab]); Pfizer (ALL [inotuzumab]). Consultant/Advisory Boards: Pfizer (ALL
[inotuzumab])."},{"name":"Maria I Aguilar, MD","credentials":["Associate Professor
of Neurology\n","Mayo Clinic Arizona"],"disclosure":""},{"name":"Vivek N Ahya,
MD","credentials":["Assistant Professor of Medicine\n","University of Pennsylvania
School of Medicine"],"disclosure":""},{"name":"Wei Ai, MD, PhD","credentials":
["Clinical Associate Professor of Medicine\n","University
of California, San Francisco"],"disclosure":""},{"name":"William C Aird,
MD","credentials":["Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Tarek Alhamad, MD, MS, FACP,
FASN","credentials":["Assistant Professor of Medicine\n","Washington University
School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support:
Mallinckrodt [Nephrotic syndrome (ACTH gel)]; Angion [BB3 analogue]. Speaker's
Bureau: Veloxis [Immunosuppression medications (Tacrolimus XR)].
Consultant/Advisory Board: Veloxis [Immunosuppression medications (Tacrolimus
XR)]."},{"name":"Harrison Alter, MD, MS, FACEP","credentials":["Attending
Physician\n","Highland Hospital – Alameda Health System, Oakland,
California\n","Associate Clinical Professor of Medicine, Division of Emergency
Medicine\n","University of California, San Francisco"],"disclosure":""},
{"name":"Richard F Ambinder, MD, PhD","credentials":["James B Murphy Professor of
Oncology\n","Johns Hopkins School of Medicine"],"disclosure":"Consultant/Advisory
Boards: Bristol-Myers Squibb [Cancer drugs (Checkpoint inhibitors)]; Viracta
[Cancer drugs (Therapeutic trial for unlicensed drug)]; Cellgenesis [Cancer drugs
(Imides, proteasome inhibitors)]; National Comprehensive Cancer Network [Hodgkin
lymphoma, HIV malignancy)]."},{"name":"Karl E Anderson, MD, FACP","credentials":
["Professor\n","The University of Texas Medical
Branch"],"disclosure":"Grant/Research/Clinical Trial Support: Alnylam
Pharmaceuticals [Acute porphyrias (RNAi therapy)]; Recordati Rare Disease [Acute
porphyrias (Hemin)]; Mitsubishi Tanabe Pharma America [Protoporphyria].
Consultant/Advisory Boards: Alnylam Pharmaceuticals [Acute porphyrias (RNAi
therapy)]; Recordati Rare Disease [Acute porphyrias (Hemin)]; Mitsubishi Tanabe
Pharma America [Protoporphyria]; Moderna Therapeutics [Acute porphyrias]."},
{"name":"Emanuele Angelucci, MD","credentials":["Head, Hematology and Transplant
Unit\n","San Martino Hospital"],"disclosure":""},{"name":"Stephen M Ansell, MD,
PhD","credentials":["Professor of Medicine, Division of Hematology\n","Mayo
Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol Myers Squibb,
Merck [immune checkpoint inhibitors (nivolumab, pembrolizumab)]."},{"name":"Joseph
H Antin, MD","credentials":["Professor of Medicine, Harvard Medical
School\n","Chief, Stem Cell Transplantation Program, Dana-Farber/Brigham and
Women’s Cancer Center"],"disclosure":""},{"name":"Gerald B Appel,
MD","credentials":["Section Editor — Glomerular Diseases\n","Professor of
Medicine\n","Columbia University College of Physicians and
Surgeons"],"disclosure":"Grant/Research/Clinical Trial Support: Regulus
Therapeutics [Alport syndrome (RG-012, for injection)]; Bristol-Myers Squibb [Focal
Segmental Glomerulosclerosis (Abatacept)]; Achillion [C3 Glomerulopathies (ACH-
0144471, tablets)]; EMD Serono [Immunoglobulin A nephropathy (Atacicept)]; Reatta
[Alport syndrome (Bardoxolone)]; Mallinkrodt [Focal Segmental Glomerulosclerosis
(Corticotropin)]; Chemocentryx [C3 Glomerulopathies (Avacopan)]; Chemocentryx
[Anti-Neutrophil Cytoplasmic Antibody Vasculitis (Avacopan)]. Speaker's Bureau:
Genentech [Vasculitis (Rituximab)]; Sanofi [Side effects (Alemtuzumab)].
Consultant/Advisory Boards: Genentech; Takeda Pharmaceuticals; Bristol-Myers
Squibb; Mallinckrodt Pharmaceuticals; EMD Serono; Merck; Pfizer; Genzyme-Sanofi;
Omeros; Achillion Pharmaceuticals; Ionis; Reatta; Chemocentryx [Immunosuppressives
(Drugs under development for immunosuppression)]."},{"name":"Donald M Arnold, MD,
MSc","credentials":["Associate Professor, Department of Medicine\n","McMaster
University\n","Canadian Blood Services"],"disclosure":"Grant/Research/Clinical
Trial Support: Novartis [ITP (eltrombopag)]; Amgen [ITP (romiplostim)]; Bristol
Meyers Squibb [ITP (investigational new drug)]; Rigel [ITP (fostamatinib)].
Consultant/Advisory Boards: Amgen [ITP (romiplostim)]; Novartis [ITP
(eltrombopag)]; Rigel [ITP (fostamatinib)]; UCB [ITP (investigational new drug)];
Dova [ITP (investigational new drug)]."},{"name":"Jon C Aster, MD","credentials":
["Professor of Pathology\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Regeneron [Hematologic
malignancies (Notch inhibitors)]; Lilly [Hematologic malignancies (Notch
inhibitors)]; Cellestia [Hematologic malignancies (Notch inhibitors)]; Anastasis
[Hematologic malignancies (Notch inhibitors)]. Equity Ownership/Stock Options:
Cellestia; Anastasis."},{"name":"John P Atkinson, MD","credentials":["Samuel B
Grant Professor of Medicine\n","Professor of Molecular Microbiology\n","Chief,
Division Rheumatology\n","Washington University School of
Medicine"],"disclosure":""},{"name":"Michael Auerbach, MD, FACP","credentials":
["Clinical Professor of Medicine\n","Georgetown University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AMAG
Pharmaceuticals; Pharmacosmos [Restless legs syndrome, iron deficiency of pregnancy
(Ferumoxytol, low molecular weight iron dextran)]. Consultant/Advisory Boards:
AMAG; Pharmacosmos; Luitpold/American Regent [Moderate to severe iron deficiency
(Low molecular weight iron dextran)]."},{"name":"Michael Avidan, MD","credentials":
["Section Editor — Surgical Critical Care\n","Professor of Anesthesiology and
Surgery\n","Washington University School of Medicine"],"disclosure":""},
{"name":"John S Axford, DSc, MD, FRCP, FRCPCH","credentials":["Section Editor —
Scleroderma\n","Emeritus Professor of Rheumatology\n","St George's University of
London"],"disclosure":""},{"name":"Bruce R Bacon, MD","credentials":["Professor of
Internal Medicine\n","Saint Louis University School of Medicine"],"disclosure":""},
{"name":"Zuhair K Ballas, MD","credentials":["Professor of Medicine\n","University
of Iowa"],"disclosure":"Consultant/Advisory Boards: Immune Deficiency Foundation
[Counseling for immunodeficiency patients and clinicians]; Checkmate Pharma [CpG in
tumor immunotherapy (Products in trial)]."},{"name":"Mark Ballow,
MD","credentials":["Professor of Pediatrics\n","All Children’s
Hospital\n","University of South Florida School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring
[Immunodeficiency (Immunoglobulin)]; Grifols [Immunoglobulin trial
(Immunoglobulin)]; Shire [Immunoglobulin trial (Immunoglobulin)]. Speaker's Bureau:
Shire [Immunodeficiency (Immunoglobulin)]; Grifols [Immunoglobulin trial
(Immunoglobulin)]. Consultant/Advisory Boards: Grifols [Immunodeficiency
(Immunoglobulin)]; CSL Behring [Immunodeficiency (Immunoglobulin)]; Shire
[Immunodeficiency (Immunoglobulin)]. Other Financial Interest (Data Safety
Monitoring Boards): Prometic; CSL Behring; Green Cross [Immunoglobulin]."},
{"name":"Rasheed A Balogun, MD","credentials":["Professor of
Medicine\n","University of Virginia"],"disclosure":""},{"name":"Subhas Banerjee,
MD","credentials":["Director of Endoscopy\n","Associate Professor of
Medicine\n","Stanford University Medical Center"],"disclosure":""},{"name":"Tracy
Batchelor, MD, MPH","credentials":["Giovanni Armenise Professor of
Neurology\n","Harvard Medical School"],"disclosure":"Grant/Research Support: Pfizer
[Glioblastoma]. Consultant/Advisory Boards: Merck [Glioblastoma (temozolomide)];
Proximagen/Upsher [Glioblastoma]; Roche [Glioblastoma (rituximab)]; Oxigene
[Glioblastoma]; Cavion [Glioblastoma]; Accerta [Lymphoma]; Amgen [Glioblastoma];
Genomicare [Brain tumors (diagnostic testing)]. Other Financial Interest: Oakstone
Publishing; Champions Biotechnology; Imedex [Neuro-Oncology CME/Education
(Educational Material)]."},{"name":"Kenneth A Bauer, MD","credentials":["Professor
of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Janssen Pharmaceuticals [Anticoagulation (Rivaroxaban)]; Pfizer [Anticoagulation
(Apixaban)]."},{"name":"Richard C Becker, MD","credentials":["Mabel Stearns
Stonehill Endowed Professor of Medicine\n","Chief, Division of Cardiovascular
Health and Disease\n","University of Cincinnati College of Medicine\n","Director
and Physician-in-Chief\n","Heart, Lung, and Vascular Institute\n","University of
Cincinnati/UC Health"],"disclosure":"Consultant/Advisory Boards: Portola; Janssen;
Ionis; Akcea Therapeutics."},{"name":"Robert M Bennett, MD, FRCP,
MACR","credentials":["Professor of Medicine\n","Oregon Health & Science
University"],"disclosure":""},{"name":"Edward J Benz, Jr, MD","credentials":
["Richard and Susan Smith Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Deciphera Pharmaceuticals,
Advantagene, Knowledge to Practice [Board of Directors]. Equity Ownership/Stock
Options: Deciphera; Advantagene; Knowledge to Practice [Stock options]. Equity
Ownership/Stock Options (Spouse): Multiple pharma company stocks held in trust
[Thalassemia (Desferioxamine)]."},{"name":"James R Berenson, MD","credentials":
["Medical and Scientific Director\n","Institute for Myeloma and Bone Cancer
Research"],"disclosure":""},{"name":"Nancy Berliner, MD","credentials":["Professor
of Medicine\n","Harvard Medical School\n","H. Franklin Bunn Professor of Hematology
and Chief, Division of Hematology \n","Brigham and Women's
Hospital"],"disclosure":""},{"name":"Jeffrey S Berns, MD","credentials":["Editor-
in-Chief — Nephrology \n","Section Editor — Dialysis\n","Professor of
Medicine\n","Perelman School of Medicine at the University of
Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Amgen [Clinical Trial EC
(Darbepoetin)]."},{"name":"Caroline Bérubé, MD","credentials":["Clinical Associate
Professor of Medicine (Hematology)\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Mark Bilsky, MD","credentials":["Attending
Neurologic Surgeon\n","Memorial Sloan-Kettering Cancer Center\n","Professor
Neurologic Surgery\n","Weill Medical College of Cornell
University"],"disclosure":""},{"name":"Donald B Bloch, MD","credentials":
["Associate
Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Almut
Böer-Auer, MD","credentials":["Director of Academics, Dermatologikum
Hamburg\n","Lecturer, Westfälischen Wilhelms-Universität
Münster"],"disclosure":""},{"name":"Jeffrey A Bogart, MD","credentials":["Professor
& Chair\n","Department of Radiation Oncology\n","Upstate Medical
University"],"disclosure":""},{"name":"Francisco A Bonilla, MD, PhD","credentials":
["Section Editor — Immunology and Immunodeficiency\n","Associate Professor of
Pediatrics\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Charles River Associates International (Germany) GmbH [Consultant(Genetics of
immunodeficiency)]; Grand Rounds Health [Consultant(Patient care)]; Green Cross,
Parexel [DSM(Immunoglobulin therapy)]; Guidepoint Global Advisors
[Consultant(General immunodeficiency)]; Health Resources Services
Administration/HHS [Consultant(Vaccine injury)]; Immune Deficiency Foundation
[Consultant(Patient care / Advisory board)]; Louis August Jonas Foundation [Board
Member]; Sarepta [Consultant(Biologic therapy)]."},{"name":"Peter A L Bonis,
MD","credentials":["Chief Medical Officer of Clinical Effectiveness (UpToDate,
Clinical Drug Information, and Emmi Solutions)\n","Deputy Editor —
Gastroenterology/Hepatology\n","Adjunct Professor of Medicine\n","Tufts University
School of Medicine"],"disclosure":""},{"name":"Susan E Boruchoff,
MD","credentials":["Professor of Medicine\n","Robert Wood Johnson Medical
School"],"disclosure":""},{"name":"Sylvia S Bottomley, MD","credentials":
["Professor of Medicine\n","The University of Oklahoma College of
Medicine"],"disclosure":""},{"name":"Beth A Bouchard, PhD","credentials":
["Assistant Professor of Biochemistry\n","The University of
Vermont"],"disclosure":""},{"name":"Daniel C Brennan, MD, FACP","credentials":
["Editor-in-Chief — Nephrology\n","Section Editor — Renal
Transplantation\n","Professor of Medicine\n","Medical Director and Co-Director of
the Comprehensive Transplant Center, Department of Internal Medicine, Division of
Nephrology\n","Johns Hopkins Medical School"],"disclosure":"Grant/Research/Clinical
Trial Support: Alexion; CareDx; Oxford Immunotech; Veloxis [Atypical hemolytic
uremic syndrome, antibody mediated rejection, delayed graft function,
immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab,
mycophenolate, antithymocyte globulin)]. Speaker's Bureau: Alexion; Sanofi;
Novartis; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection,
long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus,
belatacept, rituximab, mycophenolate, valganciclovir, antithymocyte globulin)].
Consultant/Advisory Boards: Alexion; Sanofi; Veloxis [Atypical hemolytic uremic
syndrome, antibody mediated rejection, long-term outcomes, immunosuppression,
induction (Eculizumab, tacrolimus, antithymocyte globulin)]."},{"name":"Robert A
Brodsky, MD","credentials":["Professor of Medicine and Oncology\n","Johns Hopkins
University"],"disclosure":"Grant/Research/Clinical Trial Support: Alexion, Apellis
[PNH (eculizumab)]; Apellis [PNH]. Consultant/Advisory Boards: Alexion, Achillion,
Apellis [PNH]."},{"name":"Jennifer R Brown, MD, PhD","credentials":["Associate
Professor\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Gilead; Verastem [CLL]. Consultant/Advisory Boards: Pharmacyclics;
Infinity; Janssen; Celgene; Roche/Genentech; Gilead [CLL (Ibrutinib, IPI-145,
lenalidomide, obinutuzumab, idelalisib)]; AbbVie [CLL (Venetoclax)]; Astra-Zeneca
[CLL (Acalabrutinib)]."},{"name":"Carlo Brugnara, MD","credentials":
["Professor\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Pfizer [sickle cell anemia (senicapoc)]."},{"name":"Glenn J Bubley,
MD","credentials":["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"James D Burner, MD","credentials":["Associate
Professor of Pathology\n","Medical Director of Transfusion Services\n","UT
Southwestern Medical Center"],"disclosure":"Consultant/Advisory Boards: Grifols
[Immunohematology (Blood bank instruments)]."},{"name":"Allison E Burnett, PharmD,
PhC, CACP","credentials":["Antithrombosis Stewardship Pharmacist\n","University of
New Mexico Hospital\n","Clinical Assistant Professor\n","University of New Mexico
College of Pharmacy"],"disclosure":""},{"name":"Arthur L Burnett, MD, MBA,
FACS","credentials":["Patrick C. Walsh Distinguished Professor of Urology, Cellular
and Molecular Medicine\n","Johns Hopkins
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Endo Pharmaceutical
[mechanisms of priapism]; Pfizer [mechanisms of priapism]; National Institutes of
Health [mechanisms of priapism]; Auxilium [mechanisms of priapism]; American
Medical Systems [mechanisms of priapism]; Coloplast [mechanisms of priapism]; Vivus
[mechanisms of priapism]; Acorda Therapeutics [mechanisms of priapism]; New England
Research Institute [mechanisms of priapism]; Medispec [mechanisms of priapism].
Consultant/Advisory Boards: Reflexonic LLC [mechanisms of priapism]; Genomic Health
Inc [mechanisms of priapism]."},{"name":"Matthew E Call, PhD","credentials":["Head
of Laboratory, Structural Biology Division\n","The Walter and Eliza Hall Institute
of Medical Research\n","Department of Medical Biology\n","The University of
Melbourne"],"disclosure":""},{"name":"Clara Camaschella, MD","credentials":
["Professor of Internal Medicine\n","Vita-Salute University and San Raffaele
Scientific Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Vifor
Pharma [Iron deficiency anemia (Use of ferric carboxymaltose)]."},{"name":"Michael
Camilleri, MD","credentials":["Professor of Medicine, Pharmacology, and
Physiology\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Rhythm
Pharmaceuticals [Gastroparesis (RM-131)]; Takeda [Gastroparesis (TAK954)]; Novartis
[Bile acid diarrhea (LJN452)]; AstraZeneca [Naloxegol effects on GI transit in
health]; NGM Biopharma [Functional constipation (NGM282)]; Allergan [Bile acid
malabsorption (Eluxadoline)]; ELIRA [Gastric emptying (T6 dermatome device)];
Vibrant [Vibrating capsule and constipation]. Consultant/Advisory Boards: Ironwood
[Gastroparesis (Advisory Board on treatment and management approaches)]; Allergan
[Diabetic gastroparesis]; AstraZeneca [Naloxegol and OIC]; ElobixAB [Bile acid
inhibitor for constipation]; Shire [Prucalopride for constipation]; Takeda
[Clinical trials]; Theravance [50-HT4 receptor agonists and PAMORA]; Bio-kier
[Obesity, diabetes]; OUTPOST medicine [OP687 for IBS]. Equity Ownership/Stock
Options: Dignify Therapeutics; Enterin."},{"name":"George P Canellos,
MD","credentials":["Editor-in-Chief — Oncology\n","Section Editor — Miscellaneous
Tumors\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},
{"name":"Jeffrey L Carson, MD","credentials":["Provost, New Brunswick Rutgers
Biomedical Health Sciences, Rutgers University\n","Richard C Reynolds Chair in
General Internal Medicine\n","Distinguished Professor of Medicine\n","Rutgers
Robert Wood Johnson Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Terumo BCT [Pathogen inactivation]; NIH [Transfusion thresholds in
myocardial infarction]."},{"name":"Mariana C Castells, MD, PhD","credentials":
["Professor of Medicine\n","Harvard Medical School"],"disclosure":""},
{"name":"Daniel Catovsky, MD, DSc (Med), FRCPath, FRCP, FMedSci","credentials":
["Emeritus Professor of Haematology\n","Institute of Cancer Research, Sutton,
Surrey, UK"],"disclosure":""},{"name":"Emi H Caywood, MD","credentials":["Director,
Blood and Bone Marrow Transplant\n","Nemours/Alfred I duPont Hospital for
Children"],"disclosure":""},{"name":"Nelson J Chao, MD","credentials":["Section
Editor — Bone Marrow Transplantation\n","Professor of Medicine\n","Duke University
School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Jazz
[GVHD (defibrotide)]; NIH [hematopoiesis]."},{"name":"W Winn Chatham,
MD","credentials":["Professor of Medicine\n","University of Alabama at
Birmingham"],"disclosure":""},{"name":"Athena M Cherry, PhD","credentials":
["Professor of Pathology\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Jane E Churpek, MD","credentials":["Assistant
Professor, Section of Hematology/Oncology\n","The University of
Chicago"],"disclosure":""},{"name":"Mark W Clemens, MD, FACS","credentials":
["Associate Professor, Plastic Surgery\n","MD Anderson Cancer Center, University of
Texas"],"disclosure":""},{"name":"Thomas D Coates, MD","credentials":["Professor of
Pediatrics and Pathology\n","University of Southern California School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Apopharma [Iron overload];
Celgene [Thalassemia]."},{"name":"Wilson S Colucci, MD","credentials":["Section
Editor — Heart Failure\n","Professor of Medicine\n","Boston University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Novartis [Heart failure
(Valsartan, sacubitril/valsartan)], Merck [Heart failure (Enalapril)], Amgen [Heart
failure (Ivabradine)]."},{"name":"Rebecca F Connor, MD","credentials":["Senior
Deputy Editor — UpToDate\n","Deputy Editor — Hematology"],"disclosure":""},
{"name":"Louis S Constine, MD","credentials":["Professor of Radiation Oncology and
Pediatrics\n","Vice Chair\n","University of Rochester Medical
Center"],"disclosure":""},{"name":"Timothy P Cooley, MD","credentials":["Associate
Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},
{"name":"Todd M Cooper, DO","credentials":["Associate Professor of Pediatrics
\n","University of Washington\n","Director - Leukemia Program\n","Seattle
Children's Cancer and Blood Disorders Center"],"disclosure":""},{"name":"Scott J
Cotler, MD","credentials":["Professor of Medicine\n","Director, Division
of Hepatology\n","Loyola University Medical Center"],"disclosure":""},
{"name":"Steven Coutre, MD","credentials":["Professor of Medicine\n","Stanford
University School of Medicine"],"disclosure":""},{"name":"Kendall P Crookston, MD,
PhD","credentials":["Professor, Departments of Pathology and
Medicine\n","University of New Mexico School of Medicine\n","Medical Director,
Transfusion Medicine and Therapeutic Apheresis, University of New Mexico
Hospitals\n","Medical Director, TriCore Reference Laboratories, Albuquerque,
NM"],"disclosure":""},{"name":"Sheila E Crowe, MD, FRCPC, FACP, FACG,
AGAF","credentials":["Professor of Medicine\n","University of California, San
Diego"],"disclosure":""},{"name":"Mark Crowther, MD, MSc","credentials":["Professor
of Medicine and Pathology & Molecular Medicine\n","St Joseph’s Hospital and
McMaster University"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer;
Heart & Stroke Foundation; Leo [Anticoagulation]. Consultant/Advisory Boards:
Bayer; Daiichi [Anticoagulation]; Portola [Anticoagulation reversal]; Shinogi
[Antiplatelet therapy]. Other Financial Interests: Alexion [Thrombosis (Preparation
of education materials and/or presentations)]; Boehringer Ingelheim
[Anticoagulation reversal, anticoagulation (Preparation of educational materials
and/or presentations)]; Bayer; Pfizer [Anticoagulation (Preparation of educational
materials and/or presentations)]; Bayer [Thrombosis, anticoagulant drugs
(Medicolegal activities)]."},{"name":"Christopher P Crum, MD","credentials":
["Department of Pathology\n","Brigham and Women's Hospital"],"disclosure":""},
{"name":"Adam Cuker, MD, MS","credentials":["Assistant Professor of Medicine,
Assistant Professor of Pathology & Laboratory Medicine\n","Perelman School of
Medicine University of Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial
Support: Biogen-Idec, Spark Therapeutics, T2 Biosystems, Shire Pharmaceuticals.
Consultant/Advisory Boards: Biogen-Idec, Diagnostica Stago."},{"name":"Corey
Cutler, MD, MPH, FRCP(C)","credentials":["Associate Professor of Medicine
\n","Harvard Medical School\n","Medical Director \n","Bone Marrow Transplant
Survivors Clinic\n","Division of Hematologic Malignancies\n","Dana-Farber Cancer
Institute"],"disclosure":""},{"name":"Donald Cutlip, MD","credentials":["Section
Editor — Interventional Cardiology\n","Professor of Medicine\n","Harvard Medical
School\n","Beth Israel Deaconess Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Boston Scientific
[Transcatheter aortic valve; coronary artery stent]; CeloNova [coronary artery
stent]."},{"name":"Nicholas Dainiak, MD, FACP","credentials":["Clinical Professor,
Department of Therapeutic Radiology\n","Yale University School of
Medicine\n","Medical and Technical Director\n","Radiation Emergency and Assistance
Center (REAC/TS)"],"disclosure":""},{"name":"Timothy A Damron, MD","credentials":
["Vice-Chair and David G. Murray Endowed Professor of Orthopedic Surgery\n","SUNY
Upstate Medical University"],"disclosure":"Grant/Research/Clinical Trial Support:
Stryker [Vitoss bone graft subsitute (Vitoss); Revision total joint clinical trial
(Triathlon revision total knees)]; Wright Medical [Prodense bone graft substitute
(Prodense)]."},{"name":"Matthew S Davids, MD, MMSc","credentials":["Assistant
Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Claire
Dearden, MD, BSc, FRCP, FRCPath","credentials":["Consultant Haematologist\n","The
Royal Marsden Hospital and Institute of Cancer Research,
London"],"disclosure":"Consultant/Advisory Boards: Roche [B-PLL (Rituximab)];
Gilead [B-PLL (Idelalisib)]; Janssen [B-PLL (Ibrutinib)]; Sanofi [T-PLL
(Alemtuzumab)]."},{"name":"Michael R DeBaun, MD, MPH","credentials":["Professor of
Pediatrics and Internal Medicine\n","Vanderbilt University School of
Medicine"],"disclosure":""},{"name":"H Joachim Deeg, MD","credentials":["Professor
of Medicine, University of Washington\n","Member, Fred Hutchinson Cancer Research
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Baxalta/Shire\t[GVHD
(Alpha 1 anti-trypsin)]. Consultant/Advisory Boards: Medac [transplantation
(treosulfan)]."},{"name":"Angela Dispenzieri, MD","credentials":["Serene M. and
Frances C. Durling Professor of Medicine and of Laboratory Medicine, and
Pathology\n","Mayo Clinic"],"disclosure":"Grant/Research/Clinical Trial Support:
Pfizer, Celgene, Takeda, Alnylam, Janssen, Prothena (tafamidis, lenalidomide,
pomalidomide, ixazomib, bortezomib, NEOD001]."},{"name":"Gary V Doern,
MD","credentials":["Emeritus Professor of Pathology\n","University of Iowa College
of Medicine"],"disclosure":""},{"name":"James D Douketis, MD, FRCPC, FACP,
FCCP","credentials":["Professor, Department of Medicine\n","McMaster
University"],"disclosure":"Consultant/Advisory Boards: Bayer [Venous thromboembolic
disease, atrial fibrillation (Rivaroxaban)]; Sanofi [Venous thromboembolic disease
(Enoxaparin)]; Leo Pharma [Venous thromboembolic disease (Tinzaparin)]; Janssen
[Venous thromboembolic disease, atrial fibrillation (Rivaroxaban)]."},{"name":"Reed
E Drews, MD","credentials":["Section Editor — Complications of Cancer\n","Associate
Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Jarrod
A Dudakov, PhD","credentials":["Assistant Member, Program in
Immunology\n","Clinical Research Division\n","Fred Hutchinson Cancer Research
Center"],"disclosure":""},{"name":"Christine N Duncan, MD","credentials":
["Assistant Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},
{"name":"Olive Eckstein, MD","credentials":["Assistant Professor, Pediatric
Hematology-Oncology\n","Histiocytosis & Lymphoma Team\n","Texas Children's Cancer
Center/Hematology Service \n","Baylor College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Abcam
[hemophagocytic lymphohistiocytosis (anti-interferon gamma antibody)]."},
{"name":"Keith Elkon, MD","credentials":["Mannik-Henderson Professor of
Medicine\n","Head, Division of Rheumatology\n","University of
Washington"],"disclosure":""},{"name":"Michael Emmett, MD","credentials":["Editor-
in-Chief — Nephrology \n","Section Editor — Fluid and Electrolytes\n","Chief of
Internal Medicine\n","Baylor University Medical
Center"],"disclosure":"Consultant/Advisory Boards: ZS Pharma [Treatment of
hyperkalemia (Potassium binder, zirconium silicate)]."},{"name":"Uta Erdbruegger,
MD","credentials":["Associate Professor of Medicine\n","University of
Virginia"],"disclosure":""},{"name":"Doruk Erkan, MD, MPH","credentials":
["Associate Attending Rheumatologist, Hospital for Special Surgery\n","Associate
Professor of Medicine, Weill Cornell
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Lupus Clinical
Trials Consortium; GlaxoSmithKline [Lupus (Belimumab)]; EMD Serono [lupus];
National Institutes of Health [Antiphospholipid syndrome]; Hospital for Special
Surgery Medical Education Academy [Antiphospholipid syndrome]. Consultant/Advisory
Boards: GSK (lupus); Ablynx (Antiphospholipid Syndrome)."},{"name":"Elihu H Estey,
MD","credentials":["Professor\n","University of Washington School of
Medicine"],"disclosure":""},{"name":"Zeev Estrov, MD","credentials":["Professor of
Medicine\n","University of Texas MD Anderson Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Incyte.
Consultant/Advisory Boards: Incyte."},{"name":"Amos Etzioni, MD","credentials":
["Professor Emeritus of Pediatrics and Immunology\n","The Rappaport Faculty of
Medicine, Technion, Haifa"],"disclosure":""},{"name":"Ronald J Falk,
MD","credentials":["Nan and Hugh Cullman Eminent Professor of Nephrology\n","Chair,
Department of Medicine\n","Director, UNC Kidney Center\n","University of North
Carolina-Chapel Hill"],"disclosure":""},{"name":"Harrison W Farber,
MD","credentials":["Professor of Medicine\n","Boston University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Actelion [Pulmonary
hypertension (Bosentan, macitentan, selexipag, epoprostenol)]; Gilead [Pulmonary
hypertension (Ambrisentan)]; United Therapeutics [Pulmonary hypertension
(Treprostinil)]; Bayer [Pulmonary hypertension (Epoprostenol, riociguat)]; Eli
Lilly [Pulmonary hypertension (Tadalafil)]. Speaker's Bureau: Actelion [Pulmonary
hypertension (Bosentan, macitentan, selexipag, epoprostenol)]; Bayer [Pulmonary
hypertension (Epoprostenol, riociguat)]; Gilead [Pulmonary hypertension
(Ambrisentan)]. Consultant/Advisory Boards: Actelion [Pulmonary hypertension
(Bosentan, macitentan, selexipag, epoprostenol)]; Bayer [Pulmonary hypertension
(Epoprostenol, riociguat)]; Gilead [Pulmonary hypertension (Ambrisentan)]; United
Therapeutics [Pulmonary hypertension (Treprostinil)]; Bellerophon [Pulmonary
hypertension]; Eli Lilly [Pulmonary hypertension (Tadalafil)]."},{"name":"William P
Fay, MD","credentials":["Professor of Internal Medicine \n","Director, Division of
Cardiovascular Medicine \n","University of Missouri"],"disclosure":""},
{"name":"Robert L Ferrer, MD, MPH","credentials":["Professor, Department of Family
and Community Medicine\n","University of Texas Health Science Center at San
Antonio"],"disclosure":""},{"name":"Fernando C Fervenza, MD, PhD","credentials":
["Section Editor — Glomerular Diseases \n","Professor of Medicine\n","Mayo Clinic
College of Medicine"],"disclosure":"Grant/Research/Clinical Trial support:
Genentech [Membranous nephropathy, Fibrillary GN (Rituximab)]; Mallinckrodt [IgA
nephropathy] and FSGS(Corticotropin injection gel)]; Janssen Pharmaceutical
[Monoclonal protein-mediated renal diseases (Daratumumab)]. Consultant/Advisory
Boards: Alexion pharmaceutical [complement-mediated diseases]; Visterra
pharmaceutical [complement-mediated diseases]. Employment: Mayo Clinic."},
{"name":"Maria Isabel Fiel, MD, FAASLD","credentials":["Professor of
Pathology\n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},
{"name":"Joshua
J Field, MD","credentials":["Associate Professor of Medicine\n","Medical College
of Wisconsin"],"disclosure":"Grant/Research/Clinical Trial Support: NKT
Therapeutics [sickle cell disease (NKTT120)]; Ironwood Pharmaceuticals [sickle cell
disease (IW-1701) ]; Prolong Pharmaceuticals [sickle cell disease (Sanguinate)];
Incyte Pharmaceuticals [sickle cell disease (INCB059872)]; Astellas [sickle cell
disease (regadenoson)]. Consultant/Advisory Boards: NKT Therapeutics [sickle cell
disease (NKTT120)]; Astellas [sickle cell disease (regadenoson)]; Ironwood
Pharmaceuticals [sickle cell disease (IW-1701)]."},{"name":"Jay A Fishman,
MD","credentials":["Professor of Medicine\n","Harvard Medical School\n","Director,
Transplant Infectious Disease and Compromised Host Program\n","Massachusetts
General Hospital"],"disclosure":""},{"name":"Steven Flamm, MD","credentials":
["Chief, Liver Transplantation Program\n","Professor of Medicine\n","Feinberg
School of Medicine\n","Northwestern
University"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie, Gilead
(HCV). Speaker’s Bureau:\t Abbvie, Gilead, Merck (HCV). Consultant/Advisory Boards:
Abbvie, Gilead, Merck (HCV)."},{"name":"Arnold S Freedman, MD","credentials":
["Section Editor — Lymphoproliferative Disorders\n","Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Kahr Therapeutics [SAB]. Other Financial Interest: Novartis [DMB (Ofatumumab)];
Bayer [DMB (Bayer 17833)]."},{"name":"Jane E Freedman, MD","credentials":
["Professor of Medicine\n","UMass Memorial Heart and Vascular
Center"],"disclosure":""},{"name":"W David Freeman, MD","credentials":["Professor
of Neurology \n","Mayo Clinic"],"disclosure":""},{"name":"Joy L Fridey,
MD","credentials":["Regional Medical Director\n","American Red Cross Blood
Services, Southern California"],"disclosure":""},{"name":"Jonathan W Friedberg,
MD","credentials":["Professor of Medicine\n","James P Wilmot Cancer Center,
University of Rochester"],"disclosure":"Consultant/Advisory Boards: Bayer [DSMB for
trials (Investigational agents)]; Astellas [DSMB for trials (Acalabrutinib)]."},
{"name":"Lawrence S Friedman, MD","credentials":["Section Editor — General
Gastroenterology\n","Professor of Medicine\n","Harvard Medical School\n","Tufts
University School of Medicine"],"disclosure":"Consultant/Advisory Boards:
Consultant, FDA (Antimicrobial Drugs Advisory Committee); Trustee, Newton-Wellesley
Hospital (through June 2017). Employment: Boston Health Care for the Homeless.
Other Financial Interest: Elsevier [Gastroenterology (Royalties from textbooks)];
McGraw-Hill [Gastroenterology (Royalties from textbooks)]; Wiley [Gastroenterology
(Royalties from textbooks)]; American Society for Gastrointestinal Endoscopy
[Gastroenterology and hepatology (Honorarium as newsletter editor)]."},
{"name":"Timothy J Friel, MD","credentials":["Associate Clinical Professor of
Medicine\n","University of South Florida Morsani College of
Medicine"],"disclosure":""},{"name":"Ephraim J Fuchs, MD, MBA","credentials":
["Professor of Oncology and Immunology\n","Sidney Kimmel Comprehensive Cancer
Center at Johns Hopkins"],"disclosure":""},{"name":"Barbara C Furie,
PhD","credentials":["Professor Emeritus\n","Harvard Medical
School"],"disclosure":""},{"name":"Bruce Furie, MD","credentials":["Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"William H Gaasch,
MD","credentials":["Section Editor — Valvular Disease\n","Professor of
Medicine\n","University of Massachusetts Medical School\n","Tufts University School
of Medicine\n","Senior Consultant in Cardiology\n","Lahey
Clinic"],"disclosure":""},{"name":"Paul J Gaglio, MD","credentials":["Professor of
Medicine (in Surgery)\n","Director: Hepatology Outreach\n","Columbia University
College of Physicians and Surgeons Center for Liver Disease and Transplantation
\n","\n","NY Presbyterian Hospital-Columbia University Medical Center\n","622 West
168th Street PH 14 Room 202 F\n","NY, NY 10032"],"disclosure":"Consultant/Advisory
Boards: Abbvie, Gilead, Salix [Viral hepatitis (Sofosbuvir/Ledipasvir/
Velpatasvir/Voxilaprevir/Glecaprevir Pibrenastvix)]."},{"name":"Najibah A
Galadanci, MBBS","credentials":["Bayero University/Aminu Kano Teaching
Hospital\n","Kano, Nigeria"],"disclosure":""},{"name":"John M Gansner, MD,
PhD","credentials":["Instructor in Medicine\n","Harvard Medical
School\n","Associate Physician, Division of Hematology\n","Brigham and Women's
Hospital"],"disclosure":""},{"name":"David A Garcia, MD","credentials":["Professor
of Medicine, Division of Hematology\n","University of Washington School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Daiichi Sankyo,
Janssen/Bayer [anticoagulants (edoxaban, rivaroxaban)]. Consultant/Advisory Boards:
BMS, Pfizer, Boehringer Ingelheim [anticoagulants (apixaban, dabigatran,
idarucizumab)]."},{"name":"Moira Garraus, MD","credentials":["Paediatric
Oncologist\n","Hospital San Joan de Deu"],"disclosure":""},{"name":"Benjamin P
Geisler, MD, MPH","credentials":["Instructor in Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Daniel Gelrud, MD","credentials":["Associate
Professor of Clinical Medicine\n","Florida International
University"],"disclosure":""},{"name":"Alex George, MD, PhD","credentials":
["Assistant Professor of Pediatrics\n","Baylor College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Mast therapeutics;
Pfizer; Selexys Pharmaceuticals; GBT Pharma; Sancilio Pharmaceuticals [Sickle cell
disease (Poloxamer-188, rivipansel, crizanlizumab, GBT440, SC411)]."},
{"name":"James N George, MD","credentials":["Professor of Medicine\n","University
of Oklahoma Health Sciences Center"],"disclosure":"Grant/Research/Clinical Trial
Support: Ablynx [TTP (caplacizumab)]."},{"name":"Tracy I George, MD","credentials":
["Professor\n","Department of Pathology\n","University of
Utah"],"disclosure":"Consultant/Advisory Boards: Roche [hematology (Cobas m 511
(instrument) - not available in US yet)]. Employment: ARUP Laboratories."},
{"name":"Bertil Glader, MD, PhD","credentials":["Professor of
Pediatrics\n","Stanford University School of Medicine"],"disclosure":""},
{"name":"Lucy A Godley, MD, PhD","credentials":["Professor of Medicine\n","The
University of Chicago"],"disclosure":"Grant/Research/Clinical Trial Support:
Onconova, Inc [epigenetic profiling of rigosertib response (rigosertib)]."},
{"name":"Dennis Goldfinger, MD","credentials":["Consulting Specialist, MD\n","Olive
View Medical Center"],"disclosure":""},{"name":"David Goltzman, MD","credentials":
["Professor of Medicine\n","McGill University\n","Senior Physician, Division of
Endocrinology and Department of Medicine\n","McGill University Health
Centre"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen; Eli Lilly;
Merck [Osteoporosis]. Consultant/Advisory Boards: Amgen [Osteoporosis
(Denosumab)]."},{"name":"Peter D Gorevic, MD","credentials":["Professor of
Medicine, Rheumatology\n","Mount Sinai School of Medicine"],"disclosure":""},
{"name":"Kaoru Goshima, MD","credentials":["Associate Professor,
Surgery\n","University of Arizona Health Sciences Center"],"disclosure":""},
{"name":"Mrinal M Gounder, MD","credentials":["Memorial Sloan Kettering Cancer
Center and Weill Cornell Medical College"],"disclosure":"Grant/Research/Clinical
Trial Support: Bayer [Sarcoma (Sorafenib)]. Consultant/Advisory Boards: Epizyme;
Karyopharm; Daiichi-Sankyo; Amgen [Sarcoma (None)]."},{"name":"Thomas J Graetz,
MD","credentials":["Associate Professor of Anesthesiology and Surgery
(Cardiothoracic)\n","Washington University in St. Louis School of
Medicine"],"disclosure":""},{"name":"Frank G Gress, MD","credentials":["Professor
of Medicine \n","Columbia University College of Physicians and
Surgeons"],"disclosure":""},{"name":"Thomas G Gross, MD, PhD","credentials":
["Deputy Director for Science\n","Center for Global Health, NCI, NIH,
DHHS"],"disclosure":""},{"name":"Paul A Gurbel, MD","credentials":["Director,
Cardiovascular Research, Inova Heart and Vascular Institute
\n","Professor\n","Johns Hopkins University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Haemonetics/Coramed
[Instrumentation (Thromboelastography)]; Amgen [Cardiology (evolocumab)]; DCRI
[Interventional cardiology]; NIH [Interventional cardiology (PAR-1 blocker)]; Merck
[Cardiology (PAR-1 inhibitor)]. Ionis [Cardiology]. Consultant/Advisory Boards:
Boehringer; Merck; Janssen; Bayer. Patent Holder: Platelet function testing. Equity
Ownership/Stock Options: Merck."},{"name":"Sandeep Gurbuxani, MBBS,
PhD","credentials":["Associate Professor, Section of Hematopathology, Department of
Pathology\n","University of Chicago"],"disclosure":""},{"name":"Michael Gurish,
PhD","credentials":["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Arete Discoveries [Mast cell
biology and multiple sclerosis (Proprietary research)]. Other Financial Interest:
Expert witness for Conway, Homer, and Chin-Caplan [Autoimmunity (Provide expert
opinions)]."},{"name":"Katherine A Hajjar, MD","credentials":["Professor of
Pediatrics, Brine Family Professor of Cell and Developmental Biology\n","Weill
Cornell Medicine"],"disclosure":""},{"name":"Paul Harrison, PhD","credentials":
["Senior Lecturer, School of Immunity and Infection\n","University of Birmingham
Medical School"],"disclosure":""},{"name":"Frances J Hayes, MD","credentials":
["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":""},
{"name":"Michele Heath, LP, CCP","credentials":["Perfusionist\n","Durham VA Medical
Center"],"disclosure":""},{"name":"Matthew Heeney, MD","credentials":["Assistant
Professor of Pediatrics\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Sancilio
Pharmaceuticals Company [Sickle cell treatment (SC411)];
Pfizer [Sickle cell treatment (Rivipansel)]; Astra Zeneca [Sickle cell treatment
(Ticagrelor)]. Consultant/Advisory Boards: Sancilio Pharmaceuticals Company [Sickle
cell treatment (SC411)]; AstraZeneca [Sickle cell treatment (Ticagrelor)]; Novartis
[Sickle cell treatment (Crizanlizumab)]."},{"name":"Charles H Hennekens, MD,
DrPH","credentials":["First Sir Richard Doll Professor & Senior Academic Advisor to
the Dean, Charles E. Schmidt College of Medicine, Florida Atlantic
University\n","Clinical Professor, Nova Southeastern University\n","Voluntary
Professor, University of Miami Miller School of Medicine, Meharry Medical College,
and Baylor Colle"],"disclosure":"Consultant/Advisory Boards: United States Food and
Drug Administration [Cardiovascular disease]; Pfizer [Varenicline] and its legal
counsel [Atorvastatin]. Patent Holder: Co-inventor on patents concerning
inflammatory markers and cardiovascular disease held by Brigham and Women's
Hospital [C-reactive protein]. Equity Ownership/Stock Options: SunTrustBank; The
West-Bacon Group has discretionary authority and excludes any common or preferred
stock in any pharmaceutical or medical device company."},{"name":"William L
Henrich, MD, MACP","credentials":["Professor of Medicine\n","President of the
Health Science Center\n","University of Texas Health Science Center School of
Medicine"],"disclosure":""},{"name":"John R Hess, MD, MPH","credentials":
["Professor\n","University of Washington School of Medicine"],"disclosure":"Patent
Holder: Haemonetics [Blood cell storage (additive solution -7)]; University of
Maryland; Remedium Corporation [Hemorrhage control bandage (hydrophobically
modified chitosan)]; [Hemorrhage control (clotting factor 7a and fibrinogen)]."},
{"name":"Patricia L Hibberd, MD, PhD","credentials":["Chair, Department of Global
Health\n","Boston University School of Public Health"],"disclosure":""},
{"name":"Johann Hitzler, MD, FRCP(C), FAAP","credentials":["Professor, Department
of Pediatrics\n","University of Toronto"],"disclosure":""},{"name":"Ephraim
Hochberg, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Fred H Hochberg, MD","credentials":["Professor,
Department of Neurology\n","University of California at San Diego Moores Cancer
Center"],"disclosure":""},{"name":"Maureane Hoffman, MD, PhD","credentials":
["Professor of Pathology\n","Duke University"],"disclosure":""},{"name":"Leona A
Holmberg, MD, PhD","credentials":["Associate Professor of Medicine, University of
Washington\n","Member, Fred Hutchinson Cancer Research
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Seattle Genetics,
Merck, Millennium, Sanofi [maintenance therapy after ASCT, mobilization therapy for
ASCT]. Consultant/Advisory Boards: Seattle Genetics [maintenance post-ASCT for HD],
Jazz [VOD/SOS therapy]."},{"name":"W Keith Hoots, MD","credentials":["Director,
Division of Blood Diseases and Resources\n","National Heart, Lung and Blood
Institute\n","National Institutes of Health, Bethesda, Maryland"],"disclosure":""},
{"name":"Carolyn Hoppe, MD","credentials":["Associate Hematologist/Oncologist, UCSF
Benioff Children's Hospital Oakland\n","Associate Scientist, Children's Hospital
Oakland Research Institute\n","Director, Hemoglobinopathy Reference
Laboratory"],"disclosure":"Consultant/Advisory Boards: Bio-Rad Laboratories
[Hematology/hemoglobinopathy testing (HPLC)]."},{"name":"Richard T Hoppe,
MD","credentials":["Professor of Radiation Oncology\n","Stanford University School
of Medicine"],"disclosure":""},{"name":"Terzah M Horton, MD, PhD","credentials":
["Assistant Professor, Hematology/Oncology\n","Baylor College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda
Pharmaceuticals/Millennium [Proteasome inhibitors (Bortezomib); Seattle Genetics
[Anti-CD30 antibodies (Brentuximab)]."},{"name":"Steven Horwitz, MD","credentials":
["Associate Attending\n","Memorial Sloan-Kettering Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene Corporation
[mycosis fungoides (romidepsin)]; Millennium Pharmaceuticals/Takeda [Hodgkin
lymphoma (brentuximab vedotin)]; Kyowa-Hakka-Kirin [mycosis fungoides
(mogamulizumab)]; Seattle Genetics [Hodgkin lymphoma (brentuximab vedotin)];
Spectrum Pharmaceuticals [mycosis fungoides (pralatrexate)]; Forty-Seven;
Infinity/Verastem; ADCT Therapeutics; Aileron Therapeutics. Consultant/Advisory
Boards: Celgene Corporation; Millennium Pharmaceuticals/Takeda; Kyowa-Hakka-Kirin;
Seattle Genetics; Forty-Seven; Infinity/Verastem; HUYA; BMA; Mundipharma."},
{"name":"Warner K Huh, MD","credentials":["Margaret Cameron Spain Chair in
Obstetrics/Gynecology\n","Professor, Division of Gynecologic Oncology\n","Senior
Scientist, UAB Comprehensive Cancer Center"],"disclosure":"Consultant/Advisory
Boards: Merck [Cervical cytology (HPV vaccines)]; Intuitive Surgical (Robotic
Surgery); LICOR (fluorescence imaging); InCellDx (cervical cancer screening)."},
{"name":"Russell D Hull, MBBS, MSc","credentials":["Professor of
Medicine\n","University of Calgary, Canada"],"disclosure":"Grant/Research/Clinical
Trial Support: LEO Pharma [VTE (Tinzaparin)]; Sanofi [VTE (Enoxaparin)]; Portola
[VTE (Betrixaban)]; Bayer [VTE (Rivaroxaban)]."},{"name":"Michael Ieong,
MD","credentials":["Assistant Professor of Medicine\n","Boston University School of
Medicine"],"disclosure":""},{"name":"Lesley A Inker, MD, MS","credentials":
["Associate Professor of Medicine\n","Tufts University School of
Medicine"],"disclosure":""},{"name":"Nicolas Intagliata, MD","credentials":
["Assistant Professor of Medicine\n","University of Virginia"],"disclosure":""},
{"name":"Eric Jacobsen, MD","credentials":["Assistant Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Celgene [Histiocytoses (Lenalidomide)]. Consultant/Advisory Boards:
Seattle Genetics [T cell lymphoma (Brentuximab)]; Spectrum [T cell lymphoma
(Pralatrexate, romidepsin)]; Merck (Temsirolimus); Pharmacyclics (Ibrutinib)."},
{"name":"Anuja Java, MD","credentials":["Instructor in Medicine\n","Washington
University School of Medicine"],"disclosure":""},{"name":"Richard B Johnston, Jr,
MD","credentials":["Emeritus Professor of Pediatrics\n","University of Colorado
School of Medicine\n","National Jewish Health"],"disclosure":""},{"name":"Kala
Kamdar, MD, MS Epi","credentials":["Associate Professor, Department of Pediatrics,
Section of Hematology/Oncology\n","Baylor College of Medicine"],"disclosure":""},
{"name":"Robert J Kaner, MD","credentials":["Associate Professor of Clinical
Medicine\n","Weill Medical College of Cornell University"],"disclosure":""},
{"name":"David S Kang, MD, PhD","credentials":["Director of Biomedical
Genetics\n","Rush Medical College"],"disclosure":""},{"name":"Andre A Kaplan,
MD","credentials":["Professor of Medicine\n","University of Connecticut Health
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Nipro Corporation
[Dialysis (Dialysis filters)]. Speaker's Bureau: Terumo [Plasmapheresis
(Plasmapheresis machines)]. Consultant/Advisory Boards: Vital Therapeutics
[Extracorporeal liver assist device (ELAD)]."},{"name":"Lawrence D Kaplan,
MD","credentials":["Clinical Professor of Medicine\n","University of California,
San Francisco"],"disclosure":""},{"name":"Steven M Kawut, MD","credentials":
["Associate Professor of Medicine and Epidemiology, Director, Pulmonary Vascular
Disease Program\n","Perelman School of Medicine, University of
Pennsylvania"],"disclosure":""},{"name":"Clive Kearon, MB, MRCP(I), FRCP(C),
PhD","credentials":["Jack Hirsh Professorship in Thromboembolism\n","Department of
Medicine, McMaster University"],"disclosure":"Grant/Research/Clinical Trial Support
(Spouse): Stago [VTE diagnosis (D-dimer assay)]."},{"name":"Melanie S Kennedy,
MD","credentials":["Clinical Associate Professor Emeritus\n","Department of
Pathology, The Ohio State University"],"disclosure":""},{"name":"Shakila Khan,
MD","credentials":["Associate Professor of Pediatrics\n","Mayo Clinic College of
Medicine"],"disclosure":""},{"name":"Ellen J Kim, MD","credentials":["Associate
Professor of Dermatology\n","Perelman School of Medicine at the University of
Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Kyowa Hakko
Kirin [CTCL clinical trial investigator (anti-CCR4 [KW0761, mogamulizumab])];
Solgenix [CTCL clinical trial investigator (hypericin photodynamic topical agent)];
Actelion [CTCL clinical trial investigator (nitrogen mustard gel)].
Consultant/Advisory Boards: Actelion [CTCL (nitrogen mustard gel)]."},{"name":"Youn
H Kim, MD","credentials":["Professor of Dermatology\n","Stanford University School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Esai [CTCL
(E7777/denileukin diftitox)], Kyowa Hakko Kirin [CTCL (mogamulizumab)], Merck [CTCL
(Pembromulizumab)], Millennium/Takeda [CTCL (brentuximab vedotin)], Seattle
Genetics [CTCL (brentuximab vedotin)], Soligenix [CTCL (TOPICAL SGX301)],
Tetralogic [CTCL (SHAPE)], Neumedicine [CTCL (Interleukin-12)], Innate [CTCL
(IPH4102)], Infinity Pharmaceuticals. Consultant/Advisory Boards: Actelion [CTCL],
Celgene [CTCL (Romidepsin)], Eisai [CTCL (E7777/denileukin diftitox)], Galderma
[CTCL], Kyowa Hakko Kirin [CTCL (Mogamulizumab)], Millennium/Takeda Pharma [CTCL
(Brentuximab Vedotin)], Seattle Genetics [CTCL (Brentuximab Vedotin)], Forty Seven
Inc [CTCL], Horizon Pharma [CTCL (Actimmune)], Portola Pharma [CTCL
(Cerdulatinib)], miRagen [CTCL (AntimiR-155 MRG-106)], Medivir."},
{"name":"Christina L Klein, MD","credentials":["Transplant
Nephrologist\n","Piedmont Transplant
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [CMV (CMV
vaccine)]; Chimerix [CMV (Brincidofovir)]. Speaker's Bureau: Alexion [Atypical HUS
(Eculizumab)]. Consultant/Advisory Boards: Alexion [Atypical HUS (Eculizumab)]."},
{"name":"Steven
Kleinman, MD","credentials":["Section Editor — Transfusion Medicine\n","Clinical
Professor of Pathology\n","University of British Columbia,
Vancouver"],"disclosure":"Consultant/Advisory Boards: Cerus Corp [Pathogen
reduction of blood components (Intercept Blood system)]. Equity Ownership/Stock
Options: Cerus Corp."},{"name":"Heidi D Klepin, MD, MS","credentials":["Associate
Professor of Internal Medicine, Hematology and Oncology\n","Comprehensive Cancer
Center of Wake Forest University"],"disclosure":""},{"name":"Elizabeth S Klings,
MD","credentials":["Associate Professor of Medicine\n","Boston University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Actelion
Pharmaceuticals [Pulmonary hypertension, sickle cell disease (Macitentan, bosentan,
selexipag)]; Bayer Pharmaceuticals [sickle cell disease vasculopathy (riociguat)];
Reata pharmaceuticals [Pulmonary hypertension (Bardoxolone methyl)], Arena
pharmaceuticals [Pulmonary hypertension (APD811)], Eiger pharmaceuticals [Pulmonary
hypertension (Ubenimex)]. Consultant/Advisory Boards: Pfizer (Vasoocclusive crisis,
sickle cell disease [Rivipanzel])."},{"name":"Amy D Klion, MD","credentials":
["Baltimore, MD"],"disclosure":""},{"name":"E Anders Kolb, MD","credentials":
["Director, Nemours Center for Cancer and Blood Disorders\n","Nemours/Alfred I
duPont Hospital for Children"],"disclosure":""},{"name":"Jonathan E Kolitz,
MD","credentials":["Professor of Medicine\n","Hofstra Northwell School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Celator [AML (CPX-
351)]; Boehringer-Ingelheim [AML (volasertib, BI836858)]; Millennium [AML, MDS
(pevonedistat)]; Cantex [AML (CX-01)]; Erytech Pharma [ALL (ERYASP)].
Consultant/Advisory Boards: Pharmacyclics, Seattle Genetics, Novartis, Gilead."},
{"name":"Daryl J Kor, MD","credentials":["Professor of Anesthesiology\n","Mayo
Clinic"],"disclosure":"Consultant/Advisory Boards: CSL Behring [Advisory Board for
2017-2018 (Prothrombin Complex Concentrate)]."},{"name":"Abhijit V Kshirsagar, MD,
MPH","credentials":["Associate Professor of Medicine\n","University of North
Carolina at Chapel Hill"],"disclosure":""},{"name":"Irving Kushner,
MD","credentials":["Professor Emeritus\n","Case Western Reserve
University"],"disclosure":""},{"name":"David J Kuter, MD, DPhil","credentials":
["Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Protalix, BMS [TPO
(romiplostim)]. Consultant/Advisory Boards: Amgen, Novartis, 3SBIO, Syntimmune,
Pfizer, Rigel, Argenx [Treatment of ITP (romiplostim, IVIG, monoclonal antibodies,
rhTPO)]."},{"name":"Robert A Kyle, MD","credentials":["Section Editor — Plasma Cell
Disorders\n","Professor of Medicine\n","Mayo Medical
School"],"disclosure":"Consultant/Advisory Boards: Celgene Disease Monitoring
Committee [Dysproteinemias (lenalidomide, pomalidomide)]; Bristol-Myers Squibb
Independent Monitoring Committee [Dysproteinemias (elotuzumab)]; Onyx Pharma
(Amgen) Data Monitoring Committee [Dysproteinemias (carfilzomib)]; Pharmacyclics
Data Safety Monitoring Board [Dysproteinemias (ibrutinib)]. Other Financial
Interest: Pfizer [Lecture on therapy of multiple myeloma, made comments concerning
a new Pfizer product and received an honorarium]."},{"name":"Ann S LaCasce,
MD","credentials":["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Board: BMS (DMB); Seattle Genetics
(education materials)."},{"name":"Thierry Lamy, MD, PhD","credentials":["Professor
in Hematology\n","University of Rennes, France"],"disclosure":""},{"name":"Richard
A Larson, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor —
Leukemia\n","Professor of Medicine\n","University of Chicago Pritzker School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [leukemia
(gilteritinib)]; Erytech [leukemia (eryaspase)]; Novartis [leukemia (nilotinib,
ascininib)]; Daiichi Sankyo [leukemia (quizartinib)]; Celgene [leukemia
(enasidenib)]. Consultant/Advisory Boards: Novartis [leukemia (imatinib,
nilotinib)]; Ariad Data Safety Monitoring Board [leukemia (ponatinib)];
CVS/Caremark [leukemia (drug prior authorization program)]; Celgene Data Safety
Monitoring Board [leukemia (azacitidine, durvalumab)]; Amgen [leukemia
(blinatumomab)]; Astellas [leukemia (gilteritinib)]; Jazz [leukemia (CPX-351)]."},
{"name":"Michelle M Le Beau, PhD","credentials":["Professor of
Medicine\n","University of Chicago Pritzker School of Medicine"],"disclosure":""},
{"name":"Eudocia Quant Lee, MD, MPH","credentials":["Assistant Professor of
Neurology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Genentech/Roche [Radiographic response criteria for brain Metastases]; Lilly [Brain
metastases]."},{"name":"Michael D Leise, MD","credentials":["Assistant Professor of
Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Hepatitis C
(Grazoprevir, elbasvir)]; Abbvie [Hepatitis C (Glecaprevir/Pibrentasvir)]."},
{"name":"Edgar V Lerma, MD, FACP, FASN, FAHA","credentials":["SGIM Peer
Reviewer\n","Clinical Professor of Medicine\n","University of Illinois at Chicago
College of Medicine"],"disclosure":""},{"name":"Lawrence LK Leung,
MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor — Disorders of
Hemostasis and Coagulation\n","Professor of Medicine\n","Stanford University School
of Medicine"],"disclosure":""},{"name":"Nelson Leung, MD","credentials":["Professor
of Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Omeros Corporation
[thrombotic microangiopathy]. Consultant/Advisory Boards: Prothena [amyloidosis];
Thrasos Therapeutics [myeloma kidney (cast nephropathy)]."},{"name":"Rodger A
Liddle, MD","credentials":["Professor of Medicine\n","Duke University Medical
School"],"disclosure":""},{"name":"A Michael Lincoff, MD","credentials":["Director,
Center for Clinical Research\n","Professor of Medicine\n","Cleveland Clinic Lerner
College of Medicine of Case Western Reserve
University"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen
[Dyslipidemia (Evolocumab)]; AstraZeneca [Dyslipidemia (Epanova) and coronary
artery disease (Ticagrelor)]; CSL Behring [Dyslipidemia (CSL-112)]; Edwards
[Valvular heart disease (Edwards Sapien valve)]; Eli Lilly [Dyslpidemia
(Evacetrapib)]; Esperion [Dyslipidemia (Bempedoic acid)]; Medicines Company
[Dyslipidemia (MDCO-216)]; Pfizer [COX-2 CV safety (Celecoxib)]; Roche [Diabetes
(Aleglitazar)]; AbbVie [Testosterone CV safety (AndroGel)]. Consultant/Advisory
Boards: Amgen [Dyslipidemia (Evolocumab)]; Sanofi [Diabetes (iGlarLixi)]; Novo
Nordisk [Diabetes and obesity (Semaglutide)]."},{"name":"Gregory YH Lip, MD, FRCPE,
FESC, FACC","credentials":["Professor of Cardiovascular Medicine\n","The University
of Birmingham, UK"],"disclosure":"Speaker's Bureau: Bayer [Atrial fibrillation and
thrombosis (rivaroxaban)]; BMS/Pfizer [Atrial fibrillation and thrombosis
(apixaban)]; Boehringer Ingelheim [Atrial fibrillation and thrombosis
(dabigatran)]; Daiichi-Sankyo [Atrial fibrillation and thrombosis (edoxaban)];
Medtronic [Atrial fibrillation and thrombosis]; Sanofi Aventis [Atrial fibrillation
and thrombosis]. Consultant/Advisory Boards: Bayer/Janssen [Atrial fibrillation and
thrombosis (rivaroxaban)]; BMS/Pfizer [Atrial fibrillation and thrombosis
(apixaban)]; Boehringer Ingelheim [Atrial fibrillation and thrombosis
(dabigatran)]; Daiichi-Sankyo [Atrial fibrillation and thrombosis (edoxaban)];
Medtronic [Atrial fibrillation and thrombosis]."},{"name":"M Kathryn Liszewski,
PhD","credentials":["Assistant Professor of Medicine\n","Washington University
School of Medicine"],"disclosure":""},{"name":"Michael D Lockshin, MD,
MACR","credentials":["Director\n","Barbara Volcker Center for Women and Rheumatic
Disease\n","Professor of Medicine and Obstetrics-Gynecology\n","Joan and Sanford
Weill College of Medicine of Cornell University"],"disclosure":""},{"name":"Charles
J Lockwood, MD, MHCM","credentials":["Section Editor — Obstetrics\n","Senior Vice
President, USF Health \n","Dean, Morsani College of Medicine \n","Professor,
Obstetrics and Gynecology \n","University of South Florida"],"disclosure":""},
{"name":"Jay S Loeffler, MD","credentials":["Section Editor —
Neurooncology\n","Professor of Radiation Oncology\n","Harvard Medical
School"],"disclosure":""},{"name":"Charles L Loprinzi, MD","credentials":["Regis
Professor of Breast Cancer Research\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Prevention
and treatment of chemotherapy-induced peripheral neuropathy (pregabalin)]; Pfizer
[Treating blood clots (Apixaban)]; Janssen [Preventing blood clots (Rivaroxaban)].
Consultant/Advisory Boards: Mitsubishi Tanabe Pharma [menopausal hot flashes];
PledPharma; Metys; Lpath; Mundipharma [Prevention and treatment of chemotherapy-
induced peripheral neuropathy]."},{"name":"Thomas P Loughran, Jr,
MD","credentials":["Director, University of Virginia Cancer Center\n","University
of Virginia"],"disclosure":""},{"name":"Qun Lu, MD","credentials":["Senior
Associate Consultant\n","Mayo Clinic"],"disclosure":""},{"name":"Bertram H Lubin,
MD","credentials":["Adjunct Professor of Pediatrics, University of California San
Francisco\n","CEO and President, Children’s Hospital and Research Center,
Oakland"],"disclosure":""},{"name":"Leo Luznik, MD","credentials":["Associate
Professor of Oncology\n","The Johns Hopkins University"],"disclosure":""},
{"name":"Donald H Mahoney, Jr, MD","credentials":["Section Editor — Pediatric
Hematology\n","Professor of Pediatrics\n","Baylor College of
Medicine"],"disclosure":""},{"name":"Atul Malhotra, MD","credentials":["Kenneth M
Moser Professor, Department of Medicine\n","University of California, San
Diego"],"disclosure":""},{"name":"Andrew
Malone, MB, BCh, MRCPI","credentials":["Assistant Professor of Medicine, Division
of Nephrology\n","Department of Medicine, Washington University School of
Medicine"],"disclosure":""},{"name":"John P Manis, MD","credentials":["Assistant
Professor of Pathology\n","Harvard Medical School\n","Joint Program in Transfusion
Medicine, Dep"],"disclosure":""},{"name":"Pier Mannuccio Mannucci,
MD","credentials":["Section Editor — Disorders of Hemostasis and
Coagulation\n","Professor of Internal Medicine, Angelo Bianchi Bonomi Hemophilia
and Thrombosis Center\n","University of Milan, Italy"],"disclosure":"Speaker's
Bureau: Shire, Bayer, Grifols, Kedrion Biopharma, Novo Nordisk, LFB [hemophilia,
coagulation disorders]. Consultant/Advisory Boards: Bayer, Kedrion Biopharma
[hemophilia, coagulation disorders]."},{"name":"Lawrence B Marks,
MD","credentials":["Department of Radiation Oncology\n","UNC Hospitals and
University of North Carolina at Chapel Hill"],"disclosure":"Grant/Research/Clinical
Trial Support: Vision RT [Radiation therapy (Breath-holding system to reduce
cardiac effects of radiation)]."},{"name":"Joel B Mason, MD","credentials":
["Professor of Medicine and Nutrition\n","Tufts University Schools of Medicine and
Nutrition\n","USDA Human Nutrition Research Center at Tufts
University"],"disclosure":"Grant/Research/Clinical Trial Support: Quintiles
Inc[Short bowel syndrome(Performance of clinical trials)]. Consultant/Advisory
Board: Shire Pharmaceuticals [Short bowel syndrome/malabsorption (Teduglutide)]."},
{"name":"Masao Matsuoka, MD, PhD","credentials":["Professor\n","Department of
Hematology, Kumamoto University Medical School\n","Institute for Virus Research,
Kyoto University"],"disclosure":""},{"name":"Kenneth L McClain, MD,
PhD","credentials":["Professor of Pediatrics\n","Texas Children's Cancer
Center/Hematology Service\n","Baylor College of Medicine"],"disclosure":""},
{"name":"Meredith C McCormack, MD, MHS","credentials":["Assistant Professor of
Medicine\n","Medical Director, Pulmonary Function Laboratory Pulmonary and Critical
Care Medicine Johns Hopkins University"],"disclosure":""},{"name":"Douglas
McDonald, MD, PhD","credentials":["Assistant Professor of Pediatrics\n","Boston
Children's Hospital\n","Harvard Medical School"],"disclosure":""},{"name":"Iain B
McInnes, FRCP, PhD","credentials":["Professor of Medicine\n","University of
Glasgow"],"disclosure":"Grant/Research Support: Pfizer [Inflammatory arthritis
(Etanercept, tofacitinib)]; UCB [Inflammatory arthritis (Certolizumab)]; Janssen
[Inflammatory arthritis (Ustekinumab)]; BMS [Inflammatory arthritis (Abatacept)];
Celgene. Consultant/Advisory Boards: Pfizer [Inflammatory arthritis (Etanercept,
tofacitinib)]; UCB [Inflammatory arthritis (Certolizumab)]; Janssen [Inflammatory
arthritis (Ustekinumab)]; Novartis [Inflammatory arthritis (Secukinumab)]; AbbVie
[Inflammatory arthritis (Adalimumab)]; BMS [Inflammatory arthritis (Abatacept)];
MSD [Inflammatory arthritis (Golimumab)]; Lilly [Inflammatory arthritis
(Baricitinib)]."},{"name":"Jennifer J McIntosh, DO, MS","credentials":["Assistant
Professor of Maternal Fetal Medicine\n","Medical College of
Wisconsin"],"disclosure":""},{"name":"William J McKenna, MD","credentials":
["Section Editor — Myopericardial Disease\n","Professor of
Cardiology\n","University College, London"],"disclosure":""},{"name":"C Crawford
Mechem, MD, FACEP","credentials":["Professor of Emergency Medicine\n","Perelman
School of Medicine, University of Pennsylvania"],"disclosure":""},{"name":"William
C Mentzer, MD","credentials":["Section Editor — Red Cell Disorders\n","Professor of
Pediatrics\n","University of California, San Francisco"],"disclosure":"Equity
Ownership/Stock Options: Johnson & Johnson [Anemia (Erythropoietin)]."},
{"name":"Peter A Merkel, MD, MPH","credentials":["Section Editor —
Vasculitis\n","Chief, Division of Rheumatology\n","University of
Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Actelion
[scleroderma]; Bristol-Myers Squibb [vasculitis (abatacept)]; Celgene [vasculitis
(apremilast)]; ChemoCentryx [vasculitis (avocopan)]; Genentech/Roche [vasculitis
(rituximab, tocilizumab)]; GlaxoSmithKline [vasculitis (belimumab, mepolimumab,
sirukumab)]; Kypha [vasculitis]; MedImmune [vasculitis]; TerumoBCT [vasculitis].
Consultant/Advisory Boards: Abbvie [vasculitis]; Actelion [scleroderma]; Bristol-
Myers Squibb [vasculitis]; Beoringher Ingelheim [scleroderma]; ChemoCentryx
[vasculitis (avocopan)]; Genentech/Roche[vasculitis (rituximab, tocilizumab)];
GlaxoSmithKline [vasculitis (belimumab, mepolimumab)]; InflaRx [vasculitis];
PrincipiaBio [vasculitis]; Prothena [vasculitis]; Seattle Genetics [vasculitis]."},
{"name":"Alain Meyrier, MD","credentials":["Professor of Medicine
(Emeritus)\n","Université Paris-Descartes, Paris, France"],"disclosure":""},
{"name":"Vladan Milovic, MD, PhD","credentials":["Associate Professor of
Medicine\n","Head, Department of Gastroenterology & Oncology Reha-Zentrum Bad
Reichenhall / \n","Bayerisch Gmain Klinik Hochstaufen Bayerisch Gmain \n","Bayern,
Germany"],"disclosure":""},{"name":"Sahil Mittal, MD, MS","credentials":["Assistant
Professor\n","Baylor College of Medicine"],"disclosure":""},{"name":"Kenneth J
Moise Jr, MD","credentials":["Professor of Obstetrics, Gynecology and Reproductive
Sciences\n","Professor of Pediatric Surgery\n","University of Texas School of
Medicine at Houston"],"disclosure":"Grant/Research/Clinical Trial Support: Momenta
Pharmaceutical, Inc [Transplacental characteristics of maternal antibody in HDFN].
Consultant/Advisory Boards: Momenta Pharmaceutical, Inc [Rhesus disease (Fc
receptor blocking monoclonal antibody (not yet in clinical trials))]; LFB
Biotechnologies [Development of synthetic Rhesus immune globulin (Roledumab,
synthetic Rhesus immune globulin (clinical trial planning))]."},{"name":"Craig
Moskowitz, MD","credentials":["Attending Physician, Lymphoma and Adult BMT
Services\n","Member, Memorial Sloan Kettering Cancer Center \n","Professor of
Medicine, Weill Medical College of Cornell University"],"disclosure":""},
{"name":"David B Mount, MD","credentials":["Assistant Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Ardea [Urate transport (Lesinurad)]. Consultant/Advisory Boards: ZS Pharma
[Potassium (ZS9)]; Relypsa [Potassium (Patiromer)]."},{"name":"Nikhil C Munshi,
MD","credentials":["Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Janssen [Castleman disease
(siltuximab)]."},{"name":"Anupama Narla, MD","credentials":["Assistant Professor of
Pediatrics (Hematology/Oncology)\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Mohandas Narla, DSc","credentials":["Vice
President for Research\n","New York Blood Center"],"disclosure":""},{"name":"Robert
S Negrin, MD","credentials":["Section Editor — Bone Marrow
Transplantation\n","Professor of Medicine\n","Stanford University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen [Immuno-oncology]; Jazz
Pharmaceuticals [Veno-occlusive disease (Defibrotide)]; Cell Source [Cellular
therapy]; Magenta Pharmaceuticals [Transplantation]. Equity Ownership/Stock
Options: Concentrx [Cellular immunotherapy]; Magenta Pharmaceuticals
[Transplantation]; Cell Source [Cellular therapy]. Other Financial Interest:
American Society of Hematology [Editor in Chief of \"Blood Advances\"]."},
{"name":"Carla Nester, MS, MD","credentials":["Assistant Professor\n","University
of Iowa"],"disclosure":"Grant/Research/Clinical Trial Support: Retrophin [PI – Duet
Study - Endothelin Receptor Blocker in Pediatric Patients with FSGS (RE-021)];
Avacopan [PI – A randomized, double-blind, placebo-controlled phase 2 study to
evaluate the safety and efficacy of avacopan (CCX168) in patients with CS
glomerulopathy]."},{"name":"Andrea K Ng, MD, MPH","credentials":["Professor,
Radiation Oncology, Harvard Medical School\n","Brigham and Women's
Hospital\n","Dana-Farber Cancer Institute"],"disclosure":""},{"name":"Lynnette K
Nieman, MD","credentials":["Section Editor — Adrenal Disease\n","Senior
Investigator\n","Bethesda, MD"],"disclosure":"Grant/Research/Clinical Trial
Support: HRA Pharma [Cushing's syndrome (Metapyrone)]."},{"name":"Gregory Nuttall,
MD","credentials":["Professor of Anesthesiology\n","Mayo Clinic College of
Medicine"],"disclosure":""},{"name":"Mark D Okusa, MD","credentials":["Professor of
Medicine\n","University of Virginia Health
System"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [AKI]; John Bower
Foundation [AKI]; Pfizer [Acute kidney injury (Recombinant alkaline phosphatase)].
Consultant/Advisory Boards: AM Pharma [AKI]. Patent Holder: B2 pharmaceutical
compositions having A2A adenosine receptor agonist activity; Methods and
compositions for treating inflammatory response. Equity Ownership/Stock Options:
Adenosine Therapeutics [AKI]."},{"name":"Elise A Olsen, MD","credentials":
["Professor of Dermatology and Oncology\n","Duke University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Bioniz [CTCL,
consultant]; Galderma [CTCL, investigator clinical trial]; Elorac [CTCL,
investigator clinical trial]."},{"name":"Timothy S Olson, MD, PhD","credentials":
["Assistant Professor of Pediatrics\n","Comprehensive Bone Marrow Failure Center
and Blood and Marrow Transplant Section\n","Divisions of Pediatric Oncology and
Hematology\n","The Children's Hospital of Philadelphia and University of
Pennsylvania"],"disclosure":""},{"name":"Thomas L Ortel, MD, PhD","credentials":
["Professor of Medicine & Pathology\n","Hemostasis & Thrombosis Center, Duke
University"],"disclosure":"Grant/Research/Clinical Trial Support: Instrumentation
Laboratory [coagulation laboratory testing (coagulation laboratory test instruments
and reagents)]; Stago [coagulation laboratory testing (coagulation
laboratory test instruments and reagents)]; Siemens [coagulation laboratory
testing (coagulation laboratory test instruments and reagents)]."},{"name":"Eric
Padron, MD","credentials":["Assistant Member, Malignant Hematology\n","H. Lee
Moffitt Cancer Center and Research
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Incyte, CTI,
KaloBios [CMML (ruxolitinib, pacritinib)]. Consultant/Advisory Boards: CTI, Incyte
[myelofibrosis (pacritinib)]."},{"name":"Menaka Pai, MD, FRCPC","credentials":
["Associate Professor, Hematology and Thromboembolism\n","McMaster
University"],"disclosure":"Speaker's Bureau: Bayer [VTE (rivaroxaban)].
Consultant/Advisory Boards: Bayer [VTE (rivaroxaban)]; BMS-Pfizer [VTE
(apixaban)]."},{"name":"Biff F Palmer, MD","credentials":["Professor of Internal
Medicine\n","University of Texas Southwestern Medical Center"],"disclosure":""},
{"name":"Chirag Parikh, MD, PhD","credentials":["Professor of Medicine\n","Yale
University School of Medicine"],"disclosure":""},{"name":"Stanford L Peng, MD,
PhD","credentials":["Clinical Assistant Professor\n","University of
Washington"],"disclosure":""},{"name":"Elizabeth Peralta, MD","credentials":
["Surgical Oncologist\n","Sutter Pacific Medical Foundation"],"disclosure":""},
{"name":"Ronald D Perrone, MD","credentials":["Section Editor — Cystic
Disease\n","Professor of Medicine\n","Tufts University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [Polycystic
kidney disease (Tolvaptan)]; Kadmon [Polycystic kidney disease (Tesevatinib)];
Department of Defense [Polycystic kidney disease (Metformin)]. Consultant/Advisory
Boards: Otsuka [Polycystic kidney disease (Tolvaptan)]; Novartis [Polycystic kidney
disease]; Misubishi Tanabe [Polycystic kidney disease]; Sanofi-Genzyme [Polycystic
kidney disease]."},{"name":"Jacquelyn M Powers, MD, MS","credentials":["Assistant
Professor of Pediatrics\n","Baylor College of Medicine"],"disclosure":""},
{"name":"Olga Pozdnyakova, MD","credentials":["Assistant Professor of
Pathology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Promedior [myeloproliferative neoplasms]."},{"name":"Josef T Prchal,
MD","credentials":["Professor of Medicine\n","University of
Utah"],"disclosure":""},{"name":"Elizabeth A Price, MD","credentials":["Assistant
Professor\n","Stanford University Medical Center"],"disclosure":""},{"name":"Wajeh
Y Qunibi, MD","credentials":["Professor of Medicine\n","University of Texas Health
Sciences Center"],"disclosure":""},{"name":"Alejandro A Rabinstein,
MD","credentials":["Associate Professor of Neurology \n","Mayo
Clinic"],"disclosure":""},{"name":"Benjamin A Raby, MD, MPH","credentials":
["Section Editor — Genetics\n","Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Equity Ownership/Stock Options: CureSpark, Inc [General
science]. Employment (spouse): Parexel [Hematology (CRO)] - No relevant conflict on
topic."},{"name":"Jai Radhakrishnan, MD, MS","credentials":["Professor of
Medicine\n","Columbia University Medical Center"],"disclosure":""},{"name":"Kanti R
Rai, MD","credentials":["Professor of Medicine and Molecular Medicine\n","Zucker
School of Medicine at Hofstra/Northwell"],"disclosure":"Advisory Boards:
Pharmacyclics [CLL (ibrutinib)], Gilead [CLL (idelalisib)], Roche/Genentech [CLL
(obinutuzumab, rituximab)], Cellectis [CLL (not named, generic: allogeneic CAR-T
cells)]."},{"name":"S Vincent Rajkumar, MD","credentials":["Edward W. and Betty
Knight Scripps Professor of Medicine\n","Mayo Clinic"],"disclosure":""},
{"name":"Gary E Raskob, MSc, PhD","credentials":["Professor, Biostatistics,
Epidemiology and Medicine\n","University of Oklahoma Health Sciences
Center"],"disclosure":"Consultant/Advisory Boards: Bayer Healthcare [Thromboembolic
disease (Rivaroxaban)]; BMS [Thromboembolic disease (Apixaban)]; Boehringer-
Ingelheim [Thromboembolic disease (Dabigatran)]; Daiichi Sankyo [Thromboembolic
disease (Edoxaban)]; Eli Lilly [Cancer/thrombosis (Necitumumab)]; Janssen
[Thromboembolic disease (Rivaroxaban)]; Johnson and Johnson [Thromboembolic disease
(Rivaroxaban)]; Pfizer [Thromboembolic disease (Apixaban)]; Portola [Thromboembolic
disease (Andexanet)]."},{"name":"Margaret E Rick, MD","credentials":["Adjunct
Clinical Professor of Medicine\n","Uniformed University of the Health Sciences,
Bethesda, MD"],"disclosure":""},{"name":"David J Roberts, MA, MB, D
Phil","credentials":["Professor of Hematology\n","Nuffield Dept of Clinical
Laboratory Sciences, University of Oxford"],"disclosure":""},{"name":"Dario
Roccatello, MD","credentials":["Professor of Nephrology and Clinical
Pathology\n","University of Turin Medical
School"],"disclosure":"Consultant/Advisory Boards: Genzyme [Eliglustat (Gaucher
Disease)]."},{"name":"Richard J Rodeheffer, MD","credentials":["Professor of
Medicine\n","Mayo Medical School"],"disclosure":""},{"name":"Griffin P Rodgers,
MD","credentials":["Chief, Molecular and Clinical Hematology Branch\n","National
Institutes of Health"],"disclosure":""},{"name":"Zora R Rogers, MD","credentials":
["Professor of Pediatrics\n","The University of Texas Southwestern Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Sickle cell
disease]; Novartis [tpomimetic in acquired aplastic anemia]. Consultant/Advisory
Board: Terumo BCT [medical monitor/DSMB member for PRAISE clinical trial (blood
pathogen inactivation technology)]."},{"name":"Alain H Rook, MD","credentials":
["Professor of Dermatology\n","Perelman School of Medicine at the University of
Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Soligenix [CTCL
research (hypericin clinical trial)]; Medimmune [CTCL trial]; Galderma [CTCL
trial]."},{"name":"Noel R Rose, MD, PhD","credentials":["Professor of
Pathology\n","Johns Hopkins University School of Medicine"],"disclosure":""},
{"name":"Robert S Rosenson, MD","credentials":["Section Editor —
Lipids\n","Professor of Medicine\n","Mount Sinai School of Medicine\n","Director,
Cardiometabolic Disorders\n","Mount Sinai
Heart"],"disclosure":"Grant/Research/Clinical Trial Support: Akcea [Lipids]; Amgen
[Lipids (Evolocumab)]; Sanofi [Lipids (Alirocumab)]; AstraZeneca [Antiplatelets
(Ticagrelor)]; The Medicines Company [Lipids (Inclisiran)]; Regeneron [Lipids
(Evinocumab)]. Consultant/Advisory Boards: Akcea [Lipids]; Amgen [Lipids
(Evolocumab)]; Regeneron [Lipids (Alirocumab)]; Sanofi [Lipids (Alirocumab)];
Akcea/Isis [Lipids]. Equity Ownership/Stock Options: MediMergent [Pharmacy claims
database]. Other Financial Interests: Kowa [Lipids (Pitavastatin)] honorarium."},
{"name":"David S Rosenthal, MD","credentials":["Professor of Medicine\n","Harvard
Medical School"],"disclosure":""},{"name":"Alan G Rosmarin, MD","credentials":
["Deputy Editor — Hematology\n","Professor of Medicine\n","University of
Massachusetts Medical School"],"disclosure":""},{"name":"Douglas S Ross,
MD","credentials":["Section Editor — Thyroid Disease\n","Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Board:
Medullary Thyroid Cancer Registry Consortium [Thyroid cancer]; Shire
[Hypoparathyroidism (Parathyroid hormone for injection)]; Spectrix Therapeutics,
LLC [Hypothyroidism (Thyroid hormone)]. Other Financial Interests: Abbott India
(honorarium) [Hyperthyroidism (carbimazole, levothyroxine)]; Quest Diagnostics
(honorarium) [Hyperthyroidism]."},{"name":"Brad H Rovin, MD","credentials":
["Section Editor — Glomerular Diseases \n","Professor of Medicine and
Pathology\n","The Ohio State University College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [Glomerular
Diseases/Molecular Interrogation of Kidney Biopsies, Precision
Medicine/Biomarkers]. Consultant/Advisory Boards: Alexion [Lupus Nephritis
(Eucluzimab)]; Aurinia [Lupus Nephritis, FSGS (Voclosporin)]; Biogen Idec [Lupus
Nephritis (Anti-TWEAK)]; Biomarin [Hereditary Disorders of Metabolic Disorders
(Pegvaliase)]; Bristol Myers Squibb [FSGS, MCD (Abatacept)]; Chemocentryx [Lupus
Nephritis, ANCA Vasculitis, C3 Glomerulopathy (Avacopan)]; EMD Serono [IgA
Nephropathy (Atacicept)]; Frazier Life Sciences [Lupus Nephritis]; Genentech [Lupus
Nephritis, ANCA Vasculitis (Rituximab, Obinutuzumab)]; Lupus Foundation of America
[Lupus Nephritis]; Mallinkrodt [Lupus Nephritis, FSGS (ACTHAR Gel)]; Medimmune
[Lupus Nephritis (Anti-interferon)]; Novartis [IgA Nephropathy (Factor B
Inhibitor)]; Pharmalink [IgA Nephropathy]; Retrophin [IgA Nephropathy
(Sparsenten)]; Rigel [IgA Nephropathy (Fostamatinib])."},{"name":"Jayanta Roy-
Chowdhury, MD, MRCP","credentials":["Professor of Medicine and Genetics\n","Albert
Einstein College of Medicine"],"disclosure":""},{"name":"Namita Roy-Chowdhury,
PhD","credentials":["Professor of Medicine and Genetics\n","Albert Einstein College
of Medicine"],"disclosure":""},{"name":"James L Rubenstein, MD, PhD","credentials":
["Professor of Medicine, Division of Hematology/Oncology\n","University of
California, San Francisco"],"disclosure":"Grant/Research Support: Celgene [Lymphoma
(Lenalidomide)]; Genentech [Lymphoma (Rituximab)]."},{"name":"Brenda M Sandmaier,
MD","credentials":["Professor of Medicine, University of Washington\n","Member,
Fred Hutchinson Cancer Research Center"],"disclosure":""},{"name":"David T Scadden,
MD","credentials":["Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Board: Fate [Stem cells]; Bone
Therapeutics [Orthopedics]; FOG Pharma [cancer]; Magenta Therapeutics [stem cells].
Equity Ownership/Stock Options: Fate Therapeutics; Magenta Therapeutic; Clear Creek
Bio; Agios Pharmaceuticals."},{"name":"Charles A Schiffer, MD","credentials":
["Professor of Medicine and Oncology\n","Barbara Ann Karmanos Cancer
Institute\n","Wayne State University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis, BMS,
Ariad [CML
(imatinib, nilotinib, dasatinib, ponatinib)]. Consultant/Advisory Boards: Celgene
[AML, thrombotic complications (5-azacytidine, lenalidomide)]; Pfizer [CML
(bosutinib)]; Takeda; Ambit; Pharmacyclics; Juno; Astellas [DSMB thrombotic
complications]."},{"name":"Stanley L Schrier, MD","credentials":["Editor-in-Chief —
Hematology\n","Section Editor — Myeloproliferative Disorders; Red Blood Cell
Disorders\n","Professor of Medicine\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Iris Schrijver, MD","credentials":["Adjunct
Professor of Pathology\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Peter H Schur, MD","credentials":["Editor-in-
Chief — Rheumatology\n","Section Editor — Basic Science\n","Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Sanjeev Sethi, MD,
PhD","credentials":["Professor of Laboratory Medicine and Pathology\n","Mayo Clinic
College of Medicine"],"disclosure":""},{"name":"Neeral L Shah, MD","credentials":
["Associate Professor, Division of Gastroenterology and Hepatology\n","University
of Virginia"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead
[hepatitis C]. Consultant/Advisory Boards: Dova Pharmaceuticals [(thrombopoietin
agonists)]."},{"name":"Elizabeth Shane, MD","credentials":["Professor of
Medicine\n","Columbia University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Osteoporosis
(denosumab)]. Consultant/Advisory Boards: Amgen [Osteoporosis (denosumab)]."},
{"name":"Amy D Shapiro, MD","credentials":["Medical Director\n","Indiana Hemophilia
and Thrombosis Center\n","Adjunct Professor of Pediatrics\n","Michigan State
University"],"disclosure":"Grant/Research Support: Shire [Bleeding disorders
(Antihemophilic factor, anti-inhibitor coagulant complex, vapor heated)]; Daiichi
Sankyo; Kedrion Biopharma [Bleeding disorders (Topical ophthalmologic plasminogen
concentrate)]; OPKO; [Bleeding disorders (IV long-acting recombinant factor VIIa
concentrate)]; ProMetic Life Sciences [Bleeding disorders (IV plasminogen
concentrate)]; Bioverativ[Bleeding disorders (Antihemophilic factor [recombinant],
coagulation factor IX [recombinant])]; Genentech [Bleeding disorders (Emicizumab-
kxwh)]; Novo Nordisk [Bleeding disorders (Coagulant factor VIIA [recombinant],
anti-TFP therapeutic antibody)]; Octapharma [Bleeding disorders (Antihemophilic
factor [recombinant])]. Consultant/Advisory Boards: Shire [Bleeding disorders
(Antihemophilic factor, anti-inhibitor coagulant complex, vapor heated)]; Novo
Nordisk [Bleeding disorders (Coagulant factor VIIA [recombinant])]; Novo Nordisk
Hemophilia Foundation [Hemophilia]; Bayer Healthcare Pharmaceuticals [Pediatric
hemophilia (Antihemophilic factor [recombinant])]; Bioverativ [Bleeding disorders
(Antihemophilic factor [recombinant], coagulation factor IX [recombinant])];
Genentech [Bleeding disorders (Emicizumab-kxwh)]; ProMetic Life Sciences; Kedrion
Biopharma; Sangamo Biosciences [Bleeding disorders]; Bio Products Laboratory
[Bleeding disorders (Coagulation factor X [human])]. Employment: American
Thrombosis and Hemostasis Network [Medical Director - National Hemophilia Program
Coordinating Center]."},{"name":"Robert H Shmerling, MD","credentials":["Section
Editor — Diagnostic Issues in Rheumatology\n","Associate Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Board:
Knowyourmeds [Advise on matters relating to the Company’s business, technology and
products (medication information)]."},{"name":"Claire Shovlin, PhD,
FRCP","credentials":["Reader in Clinical and Molecular Medicine, NHLI
Cardiovascular Sciences\n","Imperial College,
London"],"disclosure":"Grant/Research/Clinical Trial Support: US Department of
Defense [Stopping the Stops in HHT]. Speaker's Bureau: European Respiratory Society
[Pulmonary Arteriovenous Malformations (Meet the Expert Lecture)].
Consultant/Advisory Boards: Vernalis [HHT]."},{"name":"Colin A Sieff, MB, BCh,
FRCPath","credentials":["Associate Professor of Pediatrics\n","Boston Children's
Hospital"],"disclosure":""},{"name":"Arthur J Silvergleid, MD","credentials":
["Section Editor — Transfusion Medicine\n","Affiliate Associate Professor,
Department of Pathology and Cell Biology\n","University of South Florida, College
of Medicine\n","Medical Director, OneBlood, Inc."],"disclosure":""},
{"name":"Ashwani K Singal, MD, MS","credentials":["Associate Professor, Division of
Gastroenterology and Hepatology\n","University of Alabama at
Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: NIH, ACG
[Porphyria, alcoholic liver disease]; Gilead Sciences, Aurora Pharmaceuticals
[Alcoholic steatohepatitis, nonalcoholic steatohepatitis]; Alnylam Pharmaceuticals
[Porphyria]. Consultant/Advisory Boards: Recordati [Porphyria (Hemin)]; Alnylam
[siRNA for ALAS-1]; Gilead Sciences [Hepatitis B virus, Hepatitis C virus,
nonalcoholic steatohepatitis]; Alexion Pharmaceuticals [Fatty liver disease].
Employment: UAB."},{"name":"Daniel H Solomon, MD, MPH","credentials":["Matthew H.
Liang Distinguished Chair in Arthritis and Population Health\n","Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Pfizer [Rheumatoid arthritis (Celecoxib)]."},{"name":"Michael J Somers,
MD","credentials":["Associate Professor of Pediatrics\n","Harvard Medical
School"],"disclosure":""},{"name":"Gagan K Sood, MD","credentials":["Associate
Professor, Department of Surgery and Medicine\n","Baylor College of
Medicine"],"disclosure":""},{"name":"David P Steensma, MD","credentials":
["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Celgene [MDS (Lenalidomide,
azacitidine)]; Janssen [AML (Experimental agent)]; Takada/Millennium [MDS (None)];
Tesaro [MDS (None)]; Otsuka [MDS (Decitabine)]; Acceleron [MDS (Experimental
agent)]; H3 Biosciences [MDS (Experimental agent)]."},{"name":"Martin H Steinberg,
MD","credentials":["Professor of Medicine, Pediatrics, Pathology and Laboratory
Medicine\n","Boston University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: MyoSyntax [(High-
throughput HbF diagnostic)]; Incyte [(Cellular studies of LSD inhibitors for HbF
induction)]. Consultant/Advisory Boards: Sancillio Therapeutics. Equity
Ownership/Stock Options: Vanguard Therapeutics."},{"name":"Richard H Sterns,
MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Fluid and
Electrolytes\n","Professor Emeritus\n","University of Rochester School of Medicine
and Dentistry"],"disclosure":""},{"name":"C Philip Steuber, MD","credentials":
["Professor of Pediatric Hematology and Oncology\n","Baylor College of
Medicine"],"disclosure":""},{"name":"E Richard Stiehm, MD","credentials":["Editor-
in-Chief — Allergy and Immunology\n","Section Editor — Immunology and
Immunodeficiency\n","Distinguished Research Professor of Pediatrics\n","David
Geffen School of Medicine at UCLA"],"disclosure":"Consultant/Advisory Boards: ADMA
Biologics [Infections of respiratory syncytial virus in organ transplants
(Respiratory syncytial virus immune globulin)]."},{"name":"Stephan Stilgenbauer,
MD","credentials":["Professor of Medicine\n","Ulm
University"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie (CLL, NHL
[venetoclax]); Amgen (CLL, NHL [blinatumumab]); Boehringer-Ingelheim (CLL, NHL);
Celgene (CLL, NHL [lenalidomide]); Genentech (CLL, NHL [venetoclax, rituximab,
obinutuzumab]); Genzyme (CLL, NHL [alemtuzumab]); Gilead (CLL, NHL [idelalisib]);
GSK (CLL, NHL); Janssen (CLL, NHL [ibrutinib]); Mundipharma (CLL, NHL
[bendamustine]); Novartis (CLL, NHL); Pharmacyclics (CLL, NHL[ibrutinib]); Roche
(CLL, NHL [venetoclax, rituximab, obinutuzumab]). Consultant/Advisory Boards:
AbbVie (CLL, NHL [venetoclax]); Amgen (CLL, NHL [blinatumumab]); Boehringer-
Ingelheim (CLL, NHL); Celgene (CLL, NHL [lenalidomide]); Genentech (CLL, NHL
[venetoclax, rituximab, obinutuzumab]); Genzyme (CLL, NHL [alemtuzumab]); Gilead
(CLL, NHL [idelalisib]); GSK (CLL, NHL); Janssen (CLL, NHL [ibrutinib]);
Mundipharma (CLL, NHL [bendamustine]); Novartis (CLL, NHL); Pharmacyclics (CLL,
NHL[ibrutinib]); Roche (CLL, NHL [venetoclax, rituximab, obinutuzumab])."},
{"name":"Wendy Stock, MD","credentials":["Professor of Medicine\n","Pritzker School
of Medicine of the University of Chicago"],"disclosure":"Consultant/Advisory
Boards: Pfizer [ALL (Inotuzumab)]; Jazz [ALL (Erwinia asparaginase)]; Astellas [AML
(Gilteritinib)]."},{"name":"Richard M Stone, MD","credentials":["Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Novartis. Consultant/Advisory Boards: Abbvie, Agios, Amgen, Celator,
Celgene, Novartis, Pfizer, Jazz, FujiFilm, Ono, Orsenix."},{"name":"Michael
Stowasser, MD","credentials":["Director\n","Endocrine Hypertension Research Centre,
University of Queensland Diamantina Institute\n","Greenslopes and Princess
Alexandra Hospitals, Brisbane, Australia"],"disclosure":""},{"name":"Jason R
Stubbs, MD","credentials":["Associate Professor of Medicine\n","Division of
Nephrology & Hypertension\n","University of Kansas Medical
Center"],"disclosure":""},{"name":"Martin I Surks, MD","credentials":["Professor of
Medicine and Pathology\n","Albert Einstein College of Medicine"],"disclosure":""},
{"name":"Ritsuro Suzuki, MD, PhD","credentials":["Associate Professor, Department
of Oncology and Hematology\n","Shimane University Hospital Cancer
Center"],"disclosure":"Speaker's Bureau: Kyowa-Kirin [lymphoma (L-
asparaginase)]."},{"name":"Harold Szerlip, MD, FACP, FCCP, FASN,
FNKF","credentials":["Director, Nephrology Division, Baylor University Medical
Center, Dallas\n","Program Director, Nephrology Training Program, Baylor University
Medical Center\n","Clinical Professor of Medicine, Texas A&M College of
Medicine\n","Adjunct Professor
of Medicine, Texas College of Osteopathic Medicine"],"disclosure":""},
{"name":"Martin S Tallman, MD","credentials":["Chief, Leukemia Service, Memorial
Sloan-Kettering Cancer Center\n","Professor of Medicine\n","Weill Cornell Medical
College"],"disclosure":""},{"name":"Udaya S Tantry, PhD","credentials":["Laboratory
Director\n","Thrombosis Research Lab, \n","Inova Heart and Vascular
Institute"],"disclosure":"Consultant/Advisory Boards: AstraZeneca [Coronary artery
disease (Ticagrelor)]; Medicure [Coronary artery disease, percutaneous
intervention, and GPIIb/IIIa inhibitors]."},{"name":"Katherine Tarlock,
MD","credentials":["Research Associate\n","Fred Hutchinson Cancer Research
Center"],"disclosure":""},{"name":"Ayalew Tefferi, MD","credentials":["Professor of
Medicine and Hematology\n","Mayo Medical School"],"disclosure":""},{"name":"Amanda
M Termuhlen, MD","credentials":["Professor of Clinical Pediatrics\n","Keck School
of Medicine, University of Southern California"],"disclosure":""},{"name":"Swee Lay
Thein, MD, FRCP, FRCPath, DSc","credentials":["Chief, Sickle Cell
Branch\n","National Heart, Lung and Blood Institute\n","The National Institutes of
Health"],"disclosure":""},{"name":"Arthur C Theodore, MD","credentials":["Associate
Professor of Medicine\n","Boston University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech
[Mycophenolate (Scleroderma, Interstitial lung disease)]."},{"name":"Michael J
Thirman, MD","credentials":["Associate Professor of Medicine\n","Pritzker School of
Medicine of the University of Chicago"],"disclosure":""},{"name":"Jennifer S
Tirnauer, MD","credentials":["Deputy Editor — Hematology"],"disclosure":""},
{"name":"Marsha J Treadwell, PhD","credentials":["Clinical Scientist\n","Northern
California Comprehensive Sickle Cell Center\n","Department of
Hematology/Oncology\n","UCSF Benioff Children's Hospital
Oakland"],"disclosure":""},{"name":"R Michael Tuttle, MD","credentials":["Professor
of Medicine\n","Memorial Sloan Kettering Cancer
Center"],"disclosure":"Grant/Research Support: AstraZeneca [Thyroid cancer
(Selumetinib)]. Consultant/Advisory Boards: Bayer/Onyx [Thyroid cancer
(Sorafenib)]; Eisai [Thyroid cancer (Lenvatinib)]; Genzyme/Sanofi [Thyroid cancer
(Recombinant human TSH)]; Novo Nordisk [Thyroid cancer (Liraglutide)]; Roche
[Thyroid cancer (Thyroglobulin assay)]; Veracyte [Thyroid cancer (Gene
testing)]."},{"name":"Lynne Uhl, MD","credentials":["Associate Professor of
Pathology\n","Harvard Medical School"],"disclosure":""},{"name":"Marcel RM van den
Brink, MD, PhD","credentials":["Head, Division of Hematologic Oncology\n","Memorial
Sloan-Kettering Cancer Center"],"disclosure":"Grant/Research/Clinical Trial
Support: Seres. Consultant/Advisory Boards: Evelo."},{"name":"Richard A Van Etten,
MD, PhD","credentials":["Professor of Medicine\n","University of California,
Irvine"],"disclosure":""},{"name":"Astrid van Tubergen, MD, PhD","credentials":
["Rheumatologist\n","Maastricht University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer
[Spondyloarthritis (Etanercept)]; AbbVie [Spondyloarthritis (Adalimumab)]; UCB
[Spondyloarthritis (Certolizumab)]; Jansen-Cilag [Psoriatic arthritis
(Ustekinumab)]; Celgene [Psoriatic arthritis (Apremilast)]; MSD [Spondyloarthritis
(Infliximab, golimumab)]; Novartis [Spondyloarthritis (Secukinumab)].
Consultant/Advisory Board: Jansen-Cilag [Psoriatic arthritis (Ustekinumab)];
Novartis [Spondyloarthritis (Secukinumab)]."},{"name":"John Varga,
MD","credentials":["John and Nancy Hughes Professor of Medicine\n","Northwestern
University Feinberg School of Medicine"],"disclosure":""},{"name":"Sara R Vazquez,
PharmD, BCPS, CACP","credentials":["Clinical Pharmacist\n","University of Utah
Health"],"disclosure":""},{"name":"John Vella, MD, FACP, FRCP, FASN,
FAST","credentials":["Associate Professor of Medicine\n","Tufts University School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas;
Bristol Myers Squibb [Transplantation (CMV vaccine, belatacept)]."},{"name":"Vijaya
M Vemulakonda, MD, JD","credentials":["Associate Professor, Pediatric
Urology\n","University of Colorado School of Medicine"],"disclosure":""},
{"name":"Sebastien Viatte, MD, PhD","credentials":["Lecturer in
Genetics\n","Arthritis Research UK Centre for Genetics and Genomics\n","The
University of Manchester, UK"],"disclosure":""},{"name":"Elliott P Vichinsky,
MD","credentials":["Adjunct Professor\n","University of California San
Francisco"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [iron
chelation (deferasirox)]; ApoPharma [iron chelation (deferiprone)]."},
{"name":"Demetrios V Vlahakos, MD","credentials":["Professor of Medicine and
Nephrology, Director, Renal Unit \n","Attikon University Hospital \n","Athens
University School of Medicine\n","National and Kapodistrian University of
Athens"],"disclosure":""},{"name":"Ron Wald, MDCM, MPH, FRCPC","credentials":
["Associate Professor, Department of Medicine \n","University of
Toronto"],"disclosure":""},{"name":"Dawn Ward, MD","credentials":["Assistant
Professor, Division of Transfusion Medicine \n","David Geffen School of Medicine at
UCLA"],"disclosure":""},{"name":"Steven E Weinberger, MD","credentials":["Adjunct
Professor of Medicine\n","University of Pennsylvania School of
Medicine\n","Executive Vice President and CEO Emeritus\n","American College of
Physicians"],"disclosure":""},{"name":"Melvin P Weinstein, MD","credentials":
["Professor of Medicine and Pathology\n","Robert Wood Johnson Medical
School"],"disclosure":""},{"name":"Jeffrey Weitz, MD","credentials":["Professor of
Medicine and Biochemistry\n","McMaster
University"],"disclosure":"Consultant/Advisory Boards: Boehringer-Ingelheim
[anticoagulation (dabigatran, idarucizumab)]; Bayer/Janssen [anticoagulation
(rivaroxaban)]; Bristol Myers Squibb/Pfizer [anticoagulation (apixaban)]; Daiichi-
Sankyo [anticoagulation (edoxaban)]; Portola [anticoagulation (andexanet)]; Ionis
Pharmaceuticals, Merck, Novartis, Pfizer [anticoagulation]."},{"name":"Peter F
Weller, MD, MACP","credentials":["Editor-in-Chief — Infectious Diseases\n","Section
Editor — Tropical Medicine\n","William Bosworth Castle Professor of
Medicine\n","Harvard Medical School\n","Professor of Immunology and Infectious
Diseases\n","Harvard T. H. Chan School of Public
Health"],"disclosure":"Grant/Research/Clinical Trial Support: GlaxoSmithKline
[Anti-IL5 mAb for EGPA (Mepolizumab)]."},{"name":"Patrick Y Wen, MD","credentials":
["Section Editor — Neurooncology\n","Professor of Neurology\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Acerta [Brain tumor
(ACP196); Agios [Brain tumor (AG120, AG881); Angiochem [Brain tumor (ANG1005);
AstraZeneca [Brain tumor (Vandetanib)]; Kadmon [Brain tumor 9tesevatinib);
Karyopharm [Brain tumor (Selinexor)]; Merck [Brain tumor (Pembrolizumab)]; Novartis
[Brain tumor (Trametanib, dabrafenib, BGJ398, INC208)]; Oncoceutics [Brain tumor
(ONC201)]; Vascular Biogenics [Brain tumor (VB111)]; Roche [Brain tumor
(Bevacizumab)]; Sanofi-Aventis [Brain tumor (Plerixafor)]. Speaker's Bureau: Merck
[Brain tumor]. Consultant/Advisory Boards: Agios [Brain tumor (AG120)]; Astra
Zeneca [Brain tumor]; Cavion [Brain tumor (Mibefradil)]; Cortice Biosciences [Brain
tumor (TP12887)]; Foundation Medicine [Brain tumor (none)]; Genentech/Roche [Brain
tumor (Bevacizumab)]; Monteris [Brain tumor (Neuroblate)]; Novartis [Brain tumor
(LDK298)]; Novogen [Brain tumor (GDC0084); Regeneron [Brain tumor (PD1
antibodies)]; Vascular Biogenics [Brain tumor (VB111)]; VBI Vaccines [Brain
tumors]."},{"name":"Eelco FM Wijdicks, MD","credentials":["Professor of
Neurology\n","Mayo Medical School"],"disclosure":""},{"name":"Rein Willemze,
MD","credentials":["Professor and Chairman, Department of Dermatology\n","Leiden
University Medical Center"],"disclosure":""},{"name":"John R Wingard,
MD","credentials":["Professor of Medicine\n","University of Florida College of
Medicine"],"disclosure":"Consultant/Advisory Boards: Astellas [CMV, antifungal
drugs]; Ansun, Gilead [respiratory virus antivirals]; Merck [CMV, antifungal drugs,
vaccine]; Shire [CMV antiviral drug]; Fate Therapeutics [Cell product]; Celgene
[CAR T-cell product]."},{"name":"Joachim Yahalom, MD","credentials":["Member and
Professor of Radiation Oncology\n","Memorial Sloan-Kettering Cancer Center
\n","Cornell University Weill College of Medicine"],"disclosure":""},
{"name":"Motoko Yamaguchi, MD, PhD","credentials":["Assistant Professor, Department
of Hematology and Oncology\n","Mie University Graduate School of
Medicine"],"disclosure":""},{"name":"Amber M Yates, MD","credentials":["Assistant
Professor of Pediatrics\n","Baylor College of Medicine"],"disclosure":""},
{"name":"Leman Yel, MD","credentials":["Associate Professor Emeritus of Clinical
Medicine\n","University of California"],"disclosure":"Employment: Shire Plc
[Immunology] - No relevant conflict on topic. Equity Ownership/Stock Options: Shire
Plc."},{"name":"William F Young, Jr, MD, MSc","credentials":["Professor of
Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Consultant/Advisory
Boards: Nihon Medi-Physics Co, Ltd [Primary aldosteronism (Novel PET-based adrenal
imaging)]."},{"name":"Alan S L Yu, MB, BChir","credentials":["Harry Statland and
Solon Summerfield Professor of Medicine\n","University of Kansas Medical
Center"],"disclosure":""},{"name":"David T Yu, MD","credentials":["Emeritus
Professor\n","University of California Los Angeles"],"disclosure":""},{"name":"Shan
Yuan, MD","credentials":["Associate Professor\n","City of Hope"],"disclosure":""},
{"name":"Dana Zappetti, MD","credentials":["Assistant Professor of Medicine
\n","Weill Cornell Medical College"],"disclosure":""},{"name":"James L Zehnder,
MD","credentials":["Professor of Pathology and Medicine (Hematology)\n","Stanford
University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Novo
Nordisk [Hemostasis testing methods]; Novartis [Thrombopoietin agonists
(Eltrombopag)]; Instrumentation Laboratory [laboratory instrumentation (hemostasis
testing methods)]."},{"name":"Yanming Zhang, MD","credentials":
["Attending\n","Director of Cytogenetics Laboratory\n","Memorial Sloan Kettering
Cancer Center"],"disclosure":""},{"name":"Jeffrey Zonder, MD","credentials":
["Professor of Medicine and Oncology\n","Barbara Ann Karmanos Cancer
Institute\n","Wayne State University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene
[amyloidosis (lenalidomide, thalidomide, pomalidomide [IMiDs])].
Consultant/Advisory Boards: Celgene [myeloma, amyloidosis (IMiDs)]; Janssen
[myeloma, amyloidosis (daratumumab)]; BMS [myeloma, amyloidosis (elotuzumab)];
Seattle Genetics [myeloma, amyloidosis (investigational mAb)]; Takeda [myeloma,
amyloidosis (bortezomib, Ixazomib)]; Prothena [myeloma, amyloidosis (NEOD001)];
Amgen [myeloma, amyloidosis (carfilzomib)]. Other Financial Interest (contributor
and spouse): \tMMRF travel grant supported by Takeda and CURE magazine [Moving
Mountains for Multiple Myeloma Fundraising team for the MMRF]."},{"name":"Stéphane
Zuily, MD, MPH, PhD","credentials":["Associate Professor of Medicine, Nancy School
of Medicine of Lorraine University\n","Attending Physician, Vascular Medicine
Division, Nancy Academic Hospital"],"disclosure":""}]},{"name":"Peer
Reviewers","contributors":[{"name":"Michael Auerbach, MD, FACP","credentials":
["Clinical Professor of Medicine\n","Georgetown University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AMAG
Pharmaceuticals; Pharmacosmos [Restless legs syndrome, iron deficiency of pregnancy
(Ferumoxytol, low molecular weight iron dextran)]. Consultant/Advisory Boards:
AMAG; Pharmacosmos; Luitpold/American Regent [Moderate to severe iron deficiency
(Low molecular weight iron dextran)]."},{"name":"Joel S Bennett, MD","credentials":
["Professor of Medicine, Hematology-Oncology Division\n","University of
Pennsylvania"],"disclosure":""},{"name":"Herbert L Bonkovsky, MD","credentials":
["Adjunct Professor, University of North Carolina\n","Professor, University of
Connecticut"],"disclosure":"Grant/Research/Clinical Trial Support: Alnylam Pharma
[acute hepatic porphyrias (Givosiran)]; Gilead Sciences [PCT HCV (Harvoni)];
Recordati; Mitsubishi Tanabe [Porphyria (hematin)]. Consultant/Advisory Boards:
Alnylam Pharma [acute hepatic porphyrias (Givosiran)]; Recordati [acute hepatic
porphyrias (Panhematin)]; Mitsubishi Tanabe [Porphyria (hematin)]; Moderna [acute
hepatic porphyrias (Investigational agent not yet named)]; Stoke Pharma
[porphyrias (Possible investigational agents not yet named)]."},{"name":"Robert M
Bookchin, MD","credentials":["Professor of Medicine\n","Albert Einstein College of
Medicine"],"disclosure":"Consultant/Advisory Boards: Social Security
Administration. Equity Ownership/Stock Options: Gilead; Pfizer; CVS; Celgene;
Ionis; McKesson. Equity Ownership/Stock Options (Spouse): JT Pharma."},
{"name":"Mark Bower, PhD, FRCP, FRCPath","credentials":["Professor of
Oncology\n","Imperial College, London"],"disclosure":"Speaker's Bureau: ViiV,
Gilead, MSD, Janssen [HIV-related cancers (siltuximab, rituximab)]."},
{"name":"Patrick Brown, MD","credentials":["Director, Pediatric Leukemia
Program\n","Associate Professor of Oncology and Pediatrics\n","Sidney Kimmel
Comprehensive Cancer Center\n","Johns Hopkins University School of
Medicine"],"disclosure":""},{"name":"Carlo Brugnara, MD","credentials":
["Professor\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Pfizer [sickle cell anemia (senicapoc)]."},{"name":"Jorge J Castillo,
MD","credentials":["Assistant Professor, Harvard Medical School\n","Bing Center for
Waldenstrom Marcoglobulinemia\n","Dana-Farber Cancer
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie [WM
(venetoclax)], Millennium [WM (ixazomib)]. Consultant/Advisory Boards: Janssen
Latin America [myeloma (ibrutinib)]."},{"name":"Joel Anne Chasis,
MD","credentials":["Associate Professor of Medicine\n","University of California,
San Francisco"],"disclosure":""},{"name":"Joseph M Connors, MD","credentials":
["Chair, Lymphoma Tumor Group\n","British Colombia Cancer
Agency"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen, Bayer, Bristol
Myers-Squibb, Cephalon, F Hoffman-La Roche, Genentech, Janssen, Lilly, Merck,
NanoString Technologies, Seattle Genetics, Takeda [lymphoma treatment (multiple
pharmaceutical products)]. Patent Holder: NanoString Technologies."},
{"name":"Claire Dearden, MD, BSc, FRCP, FRCPath","credentials":["Consultant
Haematologist\n","The Royal Marsden Hospital and Institute of Cancer Research,
London"],"disclosure":"Consultant/Advisory Boards: Roche [B-PLL (Rituximab)];
Gilead [B-PLL (Idelalisib)]; Janssen [B-PLL (Ibrutinib)]; Sanofi [T-PLL
(Alemtuzumab)]."},{"name":"Michael R DeBaun, MD, MPH","credentials":["Professor of
Pediatrics and Internal Medicine\n","Vanderbilt University School of
Medicine"],"disclosure":""},{"name":"Robert J Desnick, MD, PhD","credentials":
["Professor and Chair, Department of Genetics and Genomic Sciences\n","Mount Sinai
School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Alnylam
[Acute porphyria (RNAi therapy clinical trial)]; Recordati Rare Diseases.
Consultant/Advisory Boards: Alnylam [Acute porphyria (RNAi therapy clinical
trial)]; Recordati Rare Diseases. Patent Holder: Alnylam [Acute porphyria (RNAi
therapy clinical trial)]."},{"name":"Jonathan W Friedberg, MD","credentials":
["Professor of Medicine\n","James P Wilmot Cancer Center, University of
Rochester"],"disclosure":"Consultant/Advisory Boards: Bayer [DSMB for trials
(Investigational agents)]; Astellas [DSMB for trials (Acalabrutinib)]."},
{"name":"Richard R Gammon, MD","credentials":["Medical Director - OneBlood,
Inc.\n","Assistant Professor of Pathology, University of Central Florida, College
of Medicine"],"disclosure":""},{"name":"Tomas Ganz, MD, PhD","credentials":
["Professor of Medicine and Pathology\n","David Geffen School of Medicine at
UCLA"],"disclosure":"Grant/Research/Clinical Trial Support: Keryx Pharma [Iron
metabolism (Iron Citrate)], Silarus Pharma [Iron metabolism], Akebia [Anemia and
iron metabolism]. Consultant/Advisory Boards: Akebia, Vifor Pharma, Intrinsic
LifeSciences, La Jolla Pharmaceutical Company, Keryx Pharma, Silarus Pharma [iron
metabolism and anemia (IV iron, Iron diagnostics, Minihepcidin, Iron citrate)].
Patent Holder: Multiple assigned to UCLA [Iron metabolism]. Equity Ownership/Stock
Options: Intrinsic LifeSciences, Silarus Pharma."},{"name":"Jason Gotlib, MD,
MS","credentials":["Professor of Medicine\n","Stanford University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis
[Mastocytosis (Midostaurin)]; NIH/NCI [Advanced systemic mastocytosis/mast cell
leukemia (Brentuximab vedotin)]; NIH/NCI [Systemic mastocytosis (Ibrutinib)];
Seattle Genetics [Advanced systemic mastocytosis/mast cell leukemia (Brentuximab
vedotin)]; Pharmacyclics [Systemic mastocytosis (Ibrutinib)]; Stemline
Therapeutics, Inc [High-risk myeloproliferative neoplasms (SL-401)].
Consultant/Advisory Boards: Deciphera Pharmaceuticals [Mastocytosis]; Blueprint
Medicines [Mastocytosis]; Plexxikon [Mastocytosis]."},{"name":"Lawrence D Kaplan,
MD","credentials":["Clinical Professor of Medicine\n","University of California,
San Francisco"],"disclosure":""},{"name":"Youn H Kim, MD","credentials":["Professor
of Dermatology\n","Stanford University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Esai [CTCL
(E7777/denileukin diftitox)], Kyowa Hakko Kirin [CTCL (mogamulizumab)], Merck [CTCL
(Pembromulizumab)], Millennium/Takeda [CTCL (brentuximab vedotin)], Seattle
Genetics [CTCL (brentuximab vedotin)], Soligenix [CTCL (TOPICAL SGX301)],
Tetralogic [CTCL (SHAPE)], Neumedicine [CTCL (Interleukin-12)], Innate [CTCL
(IPH4102)], Infinity Pharmaceuticals. Consultant/Advisory Boards: Actelion [CTCL],
Celgene [CTCL (Romidepsin)], Eisai [CTCL (E7777/denileukin diftitox)], Galderma
[CTCL], Kyowa Hakko Kirin [CTCL (Mogamulizumab)], Millennium/Takeda Pharma [CTCL
(Brentuximab Vedotin)], Seattle Genetics [CTCL (Brentuximab Vedotin)], Forty Seven
Inc [CTCL], Horizon Pharma [CTCL (Actimmune)], Portola Pharma [CTCL
(Cerdulatinib)], miRagen [CTCL (AntimiR-155 MRG-106)], Medivir."},{"name":"Jonathan
E Kolitz, MD","credentials":["Professor of Medicine\n","Hofstra Northwell School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Celator [AML (CPX-
351)]; Boehringer-Ingelheim [AML (volasertib, BI836858)]; Millennium [AML, MDS
(pevonedistat)]; Cantex [AML (CX-01)]; Erytech Pharma [ALL (ERYASP)].
Consultant/Advisory Boards: Pharmacyclics, Seattle Genetics, Novartis, Gilead."},
{"name":"Marcel Levi, MD, PhD","credentials":["Chief Executive
Officer\n","University College London Hospitals\n","Professor of
Medicine\n","Academic Medical Center, University of Amsterdam"],"disclosure":""},
{"name":"Raymond Liang, MD","credentials":["SH Ho Professor of Hematology and
Oncology\n","University of Hong Kong"],"disclosure":""},{"name":"Andrew Lister, MD,
FRCP, FRCPath, FRCR","credentials":["Section Editor — Lymphoproliferative
Disorders\n","Professor of Medical Oncology\n","St. Bartholomew's Hospital,
London"],"disclosure":"Consultant/Advisory Boards: Celgene [malignant lymphoma],
Pfizer [Lymphoma (anti-CD20 biosimilars)], Gilead (data monitoring committee) [CLL,
indolent lymphoma (idelalisib [CAL 101])], Roche (data monitoring committee)
[Indolent lymphoma (obinutuzumab [GA101])], Millennium/Takeda (data monitoring
committee) [Hodgkin lymphoma (brentuximab vedotin)]; Merck (pembrolizumab). Equity
Ownership/Stock Options (Spouse also):
GSK; Johnson & Johnson; AstraZeneca; Novartis; Pfizer; Hikma Pharma."},
{"name":"Thomas P Loughran, Jr, MD","credentials":["Director, University of
Virginia Cancer Center\n","University of Virginia"],"disclosure":""},
{"name":"Silvia Montoto, MD","credentials":["Senior Lecturer, Honorary
Consultant\n","Barts and The London School of Medicine and
Dentistry"],"disclosure":"Speaker's Bureau: Roche [NHL (rituximab)]. Other
Financial Interest: Gilead [travel support, NHL (idelalisib)]."},{"name":"Lori
Muffly, MD, MS","credentials":["Assistant Professor of Medicine\n","Blood and
Marrow Transplantation\n","Stanford University"],"disclosure":""},{"name":"Anupama
Narla, MD","credentials":["Assistant Professor of Pediatrics
(Hematology/Oncology)\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Peter Newburger, MD","credentials":["Section
Editor — White Blood Cell Disorders\n","Ali and John Pierce Professor of Pediatric
Hematology/Oncology\n","University of Massachusetts Medical
School"],"disclosure":""},{"name":"Enrico M Novelli, MD, MS","credentials":
["Assistant Professor of Medicine, University of Pittsburgh\n","Medical Director,
UPMC Adult Sickle Cell Anemia Program"],"disclosure":""},{"name":"Ruth F Padmore,
MD, FRCPC, PhD","credentials":["Staff Hematopathologist, The Ottawa Hospital and
Eastern Ontario Regional Laboratory Association\n","Associate Professor, University
of Ottawa"],"disclosure":""},{"name":"German A Pihan, MD","credentials":["Chief
Diagnostic Hematopathology Service, Beth Israel Deaconess Medical
Center\n","Assistant Professor of Pathology, Harvard Medical
School"],"disclosure":""},{"name":"Josef T Prchal, MD","credentials":["Professor of
Medicine\n","University of Utah"],"disclosure":""},{"name":"Andreas Rosenwald,
MD","credentials":["Professor, Institute of Pathology\n","University of Würzburg,
Germany"],"disclosure":""},{"name":"Mohammed Salhab, MD","credentials":
["Hematology/Oncology Fellow\n","University of Massachusetts Medical
School"],"disclosure":""},{"name":"Vaishali Sanchorawala, MD","credentials":
["Professor of Medicine\n","Director, Autologous Stem Cell Transplant
Program\n","Director, Amyloidosis Center\n","Boston Medical Center and Boston
University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: Prothena [AL amyloidosis (NEOD001)], Takeda [AL amyloidosis (ixazomib)].
Consultant/Advisory Boards: Caelum [AL amyloidosis (11-1F4)]."},{"name":"Stanley L
Schrier, MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor —
Myeloproliferative Disorders; Red Blood Cell Disorders\n","Professor of
Medicine\n","Stanford University School of Medicine"],"disclosure":""},
{"name":"Detlef Schuppan, MD, PhD","credentials":["Professor of Medicine, Harvard
Medical School\n","Institute for Translational Immunology\n","Research Center for
Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University,
Mainz, Germany, Division of Gastroenterology"],"disclosure":"Patent Holder:
Eurospital [Celiac disease (TG2-antibody)]. Consultant/Advisory Boards: Takeda
[Celiac disease (Celiac disease drug development)]."},{"name":"Arthur J
Silvergleid, MD","credentials":["Section Editor — Transfusion
Medicine\n","Affiliate Associate Professor, Department of Pathology and Cell
Biology\n","University of South Florida, College of Medicine\n","Medical Director,
OneBlood, Inc."],"disclosure":""},{"name":"Martin S Tallman, MD","credentials":
["Chief, Leukemia Service, Memorial Sloan-Kettering Cancer Center\n","Professor of
Medicine\n","Weill Cornell Medical College"],"disclosure":""},{"name":"Douglas M
Tollefsen, MD","credentials":["Professor of Medicine\n","Washington University
School of Medicine"],"disclosure":""},{"name":"Guido J Tricot, MD,
PhD","credentials":["Professor of Medicine, Director of BMT and Myeloma
Program\n","University of Iowa"],"disclosure":""},{"name":"Richard A Van Etten, MD,
PhD","credentials":["Professor of Medicine\n","University of California,
Irvine"],"disclosure":""},{"name":"Michael R Verneris, MD","credentials":
["Professor of Pediatrics, University of Colorado School of Medicine\n","Director
of Bone Marrow Transplantation and Cellular Therapy\n","The Barton Family Endowed
Chair of Bone Marrow Transplant"],"disclosure":"Consultant/Advisory Boards: B-
MoGen; Fate Therapeutics [Natural killer cell therapy]. Equity Ownership/Stock
Options: B-MoGen; Fate Therapeutics."},{"name":"Ravi Vij, MD, MBA","credentials":
["Professor of Medicine\n","Washington University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen, Takeda
[multiple myeloma]. Consultant/Advisory Boards: Celgene, Takeda, BMS, Janssen,
Abbvie, Amgen, Karyopharm [multiple myeloma]."},{"name":"John R Wingard,
MD","credentials":["Professor of Medicine\n","University of Florida College of
Medicine"],"disclosure":"Consultant/Advisory Boards: Astellas [CMV, antifungal
drugs]; Ansun, Gilead [respiratory virus antivirals]; Merck [CMV, antifungal drugs,
vaccine]; Shire [CMV antiviral drug]; Fate Therapeutics [Cell product]; Celgene
[CAR T-cell product]."},{"name":"Ann K Wittkowsky, PharmD, CACP, FASHP,
FCCP","credentials":["Clinical Professor \n","University of Washington School of
Pharmacy"],"disclosure":""},{"name":"Yanyun Wu, MD, PhD","credentials":["Chief
Medical Officer\n","Puget Sound Blood Center"],"disclosure":""},{"name":"James L
Zehnder, MD","credentials":["Professor of Pathology and Medicine
(Hematology)\n","Stanford University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Novo Nordisk [Hemostasis
testing methods]; Novartis [Thrombopoietin agonists (Eltrombopag)]; Instrumentation
Laboratory [laboratory instrumentation (hemostasis testing methods)]."}]}]}